Artificial Intelligence Technology Solutions (AITX) 10-Q 16 Jan 24 2024 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Nov. 30, 2023	Jan. 03, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Nov. 30, 2023
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--02-28
Entity File Number	000-55079
Entity Registrant Name	ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.
Entity Central Index Key	0001498148
Entity Tax Identification Number	27-2343603
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	10800 Galaxie Avenue
Entity Address, City or Town	Ferndale
Entity Address, State or Province	MI
Entity Address, Postal Zip Code	48220
City Area Code	877
Local Phone Number	787-6268
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		8,354,693,227

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Nov. 30, 2023	Feb. 28, 2023
Current assets:
Cash	$ 97,478	$ 939,759	[1]
Accounts receivable, net	505,438	265,024	[1]
Device parts inventory, net	2,220,159	1,637,899	[1]
Prepaid expenses and deposits	691,240	596,310	[1]
Total current assets	3,514,315	3,438,992	[1]
Operating lease asset	1,115,447	1,208,440	[1]
Revenue earning devices, net of accumulated depreciation of $1,209,664 and $779,839, respectively	2,111,896	1,235,219	[1]
Fixed assets, net of accumulated depreciation of $326,921 and $182,002, respectively	300,300	315,888	[1]
Trademarks	27,080	27,080	[1]
Investment at cost	50,000	50,000	[1]
Security deposit	17,380	21,239	[1]
Total assets	7,136,418	6,296,858	[1]
Current liabilities:
Accounts payable and accrued expenses	1,539,601	1,343,379	[1]
Advances payable- related party	1,594	1,594	[1]
Customer deposits	78,467	9,900	[1]
Current operating lease liability	229,016	248,670	[1]
Current portion of deferred variable payment obligation	764,702	542,177	[1]
Loan payable - related party	299,286	206,516	[1]
Incentive compensation plan payable	1,166,000	979,000	[1]
Current portion of loans payable, net of discount of $1,129,801 and $1,651,597	8,349,678	9,918,389	[1]
Vehicle loan - current portion	38,522	38,522	[1]
Current portion of accrued interest payable	3,992,259	2,761,446	[1]
Total current liabilities	16,459,125	16,049,593	[1]
Non-current operating lease liability	881,816	950,541	[1]
Loans payable, net of discount of $4,305,396 and $4,130,291, respectively	18,688,471	15,554,069	[1]
Deferred variable payment obligation	2,525,000	2,525,000	[1]
Accrued interest payable	4,774,660	3,060,656	[1]
Total liabilities	43,329,072	38,139,859	[1]
Stockholders' deficit:
Preferred stock, value			[1]
Common Stock, $0.00001 par value; 10,000,000,000 shares authorized 7,715,143,227 and 5,848,741,599 shares issued, issuable and outstanding, respectively	77,152	58,489	[1]
Additional paid-in capital	89,160,341	80,247,252	[1]
Preferred stock to be issued	99,086	99,086	[1]
Accumulated deficit	(125,535,116)	(112,253,711)	[1]
Total stockholders' deficit	(36,192,654)	(31,843,001)	[1]
Total liabilities and stockholders' deficit	7,136,418	6,296,858	[1]
Series G Preferred Stock [Member]
Stockholders' deficit:
Preferred stock, value			[1]
Series E Preferred Stock [Member]
Stockholders' deficit:
Preferred stock, value	3,350	3,350	[1]
Total stockholders' deficit	3,350	3,350
Series F Preferred Stock [Member]
Stockholders' deficit:
Preferred stock, value	2,533	2,533	[1]
Total stockholders' deficit	$ 101,619	$ 101,619
[1]Derived from audited information

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Nov. 30, 2023	Feb. 28, 2023
Accumulated depreciation, revenue earning devices	$ 1,209,664	$ 779,839
Accumulated depreciation, fixed assets	326,921	182,002
Discount of current portion of loans payable	1,129,801	1,651,597
Discount of loans payable	$ 4,305,396	$ 4,130,291
Preferred stock, authorized	15,545,650	15,545,650
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per shares)	$ 0.00001	$ 0.00001
Common stock, authorized	10,000,000,000	10,000,000,000
Common stock, shares, issued	7,715,143,227	5,848,741,599
Common stock, shares, outstanding	7,715,143,227	5,848,741,599
Series G Preferred Stock [Member]
Preferred stock, authorized	100,000	100,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Preferred stock, par value (in dollars per shares)	$ 0.001	$ 0.001
Series E Preferred Stock [Member]
Preferred stock, authorized	4,350,000	4,350,000
Preferred stock, shares issued	3,350,000	3,350,000
Preferred stock, shares outstanding	3,350,000	3,350,000
Preferred stock, par value (in dollars per shares)	$ 0.001	$ 0.001
Series F Preferred Stock [Member]
Preferred stock, authorized	4,350	4,350
Preferred stock, shares issued	2,533	2,533
Preferred stock, shares outstanding	2,533	2,533
Preferred stock, par value (in dollars per shares)	$ 1	$ 1

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		9 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2023	Nov. 30, 2022
Income Statement [Abstract]
Revenues	$ 596,980	$ 402,399	$ 1,368,551	$ 1,055,040
Cost of Goods Sold	135,914	125,960	316,439	453,898
Gross Profit	461,066	276,439	1,052,112	601,142
Operating expenses:
Research and development (Note 10)	557,126	813,313	2,243,431	2,800,834
General and administrative	2,009,047	2,123,768	6,423,951	6,762,602
Depreciation and amortization	215,763	92,855	574,746	332,643
Operating lease cost and rent	64,081	61,005	189,164	194,653
Total operating expenses	2,846,017	3,090,941	9,431,292	10,090,732
Loss from operations	(2,384,951)	(2,814,502)	(8,379,180)	(9,489,590)
Other income (expense), net:
Change in fair value of derivative liabilities				3,595
Interest expense	(1,581,533)	(1,271,158)	(4,940,965)	(3,448,208)
Gain  (loss) on settlement of debt			38,740	3,992
Total other income (expense), net	(1,581,533)	(1,271,158)	(4,902,225)	(3,440,621)
Net Loss	$ (3,966,484)	$ (4,085,660)	$ (13,281,405)	$ (12,930,211)
Net income (loss) per share - basic	$ 0	$ 0	$ 0	$ 0
Net income ( loss) per share - diluted	$ 0	$ 0	$ 0	$ 0
Weighted average common share outstanding - basic	7,294,775,879	5,140,405,652	6,606,988,956	4,969,080,716
Weighted average common share outstanding - diluted	7,294,775,879	5,140,405,652	6,606,988,956	4,969,080,716

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' DEFICIT (Unaudited) - USD ($)	Series E Preferred Stock [Member]	Series F Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Feb. 28, 2022	$ 3,350	$ 101,618	$ 47,353	$ 73,015,576	$ (94,144,254)	$ (20,976,357)
Beginning balance, (in shares) at Feb. 28, 2022	3,350,000	2,532	4,735,210,360
Issuance of shares, net of issuance costs			$ 1,339	1,643,883		1,645,222
Issuance of shares, net of issuance costs (in shares)			133,881,576
Rounding				(1)		(1)
Net income					(4,671,686)	(4,671,686)
Ending balance, value at May. 31, 2022	$ 3,350	$ 101,618	$ 48,692	74,659,458	(98,815,940)	(24,002,822)
Ending balance, (in shares) at May. 31, 2022	3,350,000	2,532	4,869,091,936
Beginning balance, value at Feb. 28, 2022	$ 3,350	$ 101,618	$ 47,353	73,015,576	(94,144,254)	(20,976,357)
Beginning balance, (in shares) at Feb. 28, 2022	3,350,000	2,532	4,735,210,360
Net income						(12,930,211)
Ending balance, value at Nov. 30, 2022	$ 3,350	$ 101,619	$ 52,607	76,421,377	(107,074,465)	(30,495,512)
Ending balance, (in shares) at Nov. 30, 2022	3,350,000	2,533	5,260,515,892
Beginning balance, value at May. 31, 2022	$ 3,350	$ 101,618	$ 48,692	74,659,458	(98,815,940)	(24,002,822)
Beginning balance, (in shares) at May. 31, 2022	3,350,000	2,532	4,869,091,936
Issuance of shares, net of issuance costs			$ 1,917	1,889,350		1,891,267
Issuance of shares, net of issuance costs (in shares)			191,691,135
Net income					(4,172,865)	(4,172,865)
Cashless exercise of warrants			$ 97	(97)
Cashless exercise of warrants (in shares)			9,688,179
Relative fair value of warrants issued with debt				404,374		404,374
Cancelled shares			$ (171)	171
Cancelled Shares (in shares)			(17,116,894)
Exchange of 955,000,000 warrants for debt				(2,960,500)		(2,960,500)
Shares as payment for services			$ 100	118,400		118,500
Shares as payment for services (in shares)			10,000,000
Ending balance, value at Aug. 31, 2022	$ 3,350	$ 101,618	$ 50,635	74,111,156	(102,988,805)	(28,722,046)
Ending balance, (in shares) at Aug. 31, 2022	3,350,000	2,532	5,063,354,356
Issuance of shares, net of issuance costs			$ 1,972	1,119,518		1,121,490
Issuance of shares, net of issuance costs (in shares)			197,161,536
Net income					(4,085,660)	(4,085,660)
Relative fair value of warrants issued with debt				(10,424)		(10,424)
Relative fair value of Series F warrants issued with debt		$ 1		1,201,127		1,201,128
Relative fair value of Series F warrants issued with debt (in shares)		1
Ending balance, value at Nov. 30, 2022	$ 3,350	$ 101,619	$ 52,607	76,421,377	(107,074,465)	(30,495,512)
Ending balance, (in shares) at Nov. 30, 2022	3,350,000	2,533	5,260,515,892
Beginning balance, value at Feb. 28, 2023	$ 3,350	$ 101,619	$ 58,489	80,247,252	112,253,711	(31,843,001)	[1]
Beginning balance, (in shares) at Feb. 28, 2023	3,350,000	2,533	5,848,741,599
Issuance of shares, net of issuance costs			$ 2,809	1,316,100		1,318,909
Issuance of shares, net of issuance costs (in shares)			280,929,190
Net income					(4,555,193)	(4,555,193)
Relative fair value of Series F warrants issued with loans payable				947,447		947,447
Stock based compensation				52,721		52,721
Ending balance, value at May. 31, 2023	$ 3,350	$ 101,619	$ 61,298	82,563,520	116,808,904	(34,079,117)
Ending balance, (in shares) at May. 31, 2023	3,350,000	2,533	6,129,670,789
Beginning balance, value at Feb. 28, 2023	$ 3,350	$ 101,619	$ 58,489	80,247,252	112,253,711	(31,843,001)	[1]
Beginning balance, (in shares) at Feb. 28, 2023	3,350,000	2,533	5,848,741,599
Net income						(13,281,405)
Ending balance, value at Nov. 30, 2023	$ 3,350	$ 101,619	$ 77,152	89,160,341	125,535,116	(36,192,654)
Ending balance, (in shares) at Nov. 30, 2023	3,350,000	2,533	7,715,143,227
Beginning balance, value at May. 31, 2023	$ 3,350	$ 101,619	$ 61,298	82,563,520	116,808,904	(34,079,117)
Beginning balance, (in shares) at May. 31, 2023	3,350,000	2,533	6,129,670,789
Issuance of shares, net of issuance costs			$ 9,036	4,787,087		4,796,123
Issuance of shares, net of issuance costs (in shares)			903,636,004
Net income					(4,759,728)	(4,759,728)
Shares as payment for services			$ 65	44,395		44,460
Shares as payment for services (in shares)			6,500,000
Stock based compensation				50,713		50,713
Ending balance, value at Aug. 31, 2023	$ 3,350	$ 101,619	$ 70,399	87,445,715	(121,568,632)	(33,947,549)
Ending balance, (in shares) at Aug. 31, 2023	3,350,000	2,533	7,039,806,793
Issuance of shares, net of issuance costs			$ 6,753	1,405,405		1,412,158
Issuance of shares, net of issuance costs (in shares)			675,336,434
Net income					3,966,484	(3,966,484)
Relative fair value of Series F warrants issued with debt				261,759		261,759
Stock based compensation				47,462		47,462
Ending balance, value at Nov. 30, 2023	$ 3,350	$ 101,619	$ 77,152	$ 89,160,341	$ 125,535,116	$ (36,192,654)
Ending balance, (in shares) at Nov. 30, 2023	3,350,000	2,533	7,715,143,227
[1]Derived from audited information

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' DEFICIT (Unaudited) (Parenthetical) - USD ($)	3 Months Ended
	Nov. 30, 2023	Aug. 30, 2023	May 31, 2023	Nov. 30, 2022	Aug. 31, 2022	May 31, 2022
Statement of Stockholders' Equity [Abstract]
Issuance cost of shares	$ 56,320	$ 176,672	$ 81,285	$ 68,732	$ 95,293	$ 117,157
Exchange of warrants for debt issuance					955,000,000

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	9 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
CASH FLOWS USED IN OPERATING ACTIVITIES:
Net loss	$ (13,281,405)	$ (12,930,211)
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	574,746	332,643
Bad debts expense	26,730	224,215
Inventory provision		90,000
Reduction of right of use asset	88,378	84,298
Accretion of lease liability	99,248	107,187
Stock based compensation	337,896	481,000
Change in fair value of derivative liabilities		(3,595)
Amortization of debt discounts	1,755,897	1,094,388
(Gain) loss on settlement of debt	(38,740)	(3,992)
Increase in related party accrued payroll and interest	92,770	9,720
Changes in operating assets and liabilities:
Accounts receivable	(267,144)	(258,790)
Prepaid expenses	(90,315)	(224,476)
Device parts inventory	(2,004,189)	(805,257)
Accounts payable and accrued expenses	266,666	197,317
Customer deposits	68,567	(7,617)
Operating lease liabilities	(174,874)	(191,485)
Current portion of deferred variable payment obligation for payments	222,525	171,550
Accrued interest payable	2,944,817	1,749,833
Net cash used in operating activities	(9,378,427)	(9,883,272)
CASH FLOWS USED IN INVESTING ACTIVITIES:
Purchase of fixed assets	(13,903)	(217,601)
Acquisition of trademarks
Reimbursement of security deposit	3,859
Net cash used in investing activities	(10,044)	(217,601)
CASH FLOWS FROM FINANCING ACTIVITIES:
Share proceeds net of issuance costs	7,527,190	4,657,979
Proceeds from loans payable	1,400,000	2,600,000
Repayment of loans payable	(381,000)	(1,711,009)
Proceeds from convertible debt and warrants issued		619,250
Net cash provided by financing activities	8,546,190	6,166,220
Net change in cash	(842,281)	(3,934,653)
Cash, beginning of period	939,759	4,648,146
Cash, end of period	97,478	713,493
Supplemental disclosure of cash and non-cash transactions:
Cash paid for interest	17,726	405,117
Cash paid for income taxes
Noncash investing and financing activities:
Transfer from device parts inventory to revenue earning devices	1,421,979	672,534
Shares issued for services	44,460
Exchange of warrants for debt		3,000,000
Discount applied to face value of loans	200,000	434,500
Warrants issued as part of debt	1,209,206
Exercise of warrants		97
Series F preferred shares and warrants issued for debt		1,240,628
Cancellation of Series E preferred shares and common shares		$ 171

GENERAL INFORMATION

GENERAL INFORMATION	9 Months Ended
	Nov. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GENERAL INFORMATION	1. GENERAL INFORMATION Artificial Intelligence Technology Solutions Inc. (“AITX” or the “Company”) was incorporated in Florida on March 25, 2010 and reincorporated in Nevada on February 17, 2015. On August 24, 2018, Artificial Intelligence Technology Solutions Inc., changed its name from On the Move Systems Corp (“OMVS”). Robotic Assistance Devices, LLC (“RAD”), was incorporated in the State of Nevada on July 26, 2016 as a Limited Liability Company. On July 25, 2017, Robotic Assistance Devices LLC converted to a C Corporation, Robotic Assistance Devices, Inc., through the issuance of 10,000 On August 28, 2017, AITX completed the acquisition of RAD (the “Acquisition”), whereby AITX acquired all the ownership and equity interest in RAD for 3,350,000 2,450 The Acquisition was treated as a reverse recapitalization effected by a share exchange for financial accounting and reporting purposes since substantially all of AITX’s operations were disposed of as part of the consummation of the transaction. Therefore, no goodwill or other intangible assets were recorded by AITX as a result of the Acquisition. RAD is treated as the accounting acquirer as its stockholders control the Company after the Acquisition, even though AITX was the legal acquirer. As a result, the assets and liabilities and the historical operations that are reflected in these financial statements are those of RAD as if RAD had always been the reporting company.

GOING CONCERN

GOING CONCERN	9 Months Ended
	Nov. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN	2. GOING CONCERN The accompanying unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern. For the nine months ended November 30, 2023, the Company had negative cash flow from operating activities of $ 9,378,427 125,535,116 12,944,810 The Company does not have the resources at this time to repay its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business. Management has plans to address the Company’s financial situation as follows: Management is committed to raise either non-dilutive funds or minimally dilutive funds. There is no assurance that these funds will be able to be raised nor can we provide assurance that these possible raises may not have dilutive effects. In March 2023, the Company entered into an equity financing agreement whereby an investor will purchase up to $ 12,500,000 200,000 300,000 Management is committed to raise either non-dilutive funds or minimally dilutive funds. There is no assurance that these funds will be able to be raised nor can we provide assurance that these possible raises may not have dilutive effects. The Company year to date November 30, 2023 has raised an additional $ 7.5 1.4 1.5

ACCOUNTING POLICIES

ACCOUNTING POLICIES	9 Months Ended
	Nov. 30, 2023
Accounting Policies [Abstract]
ACCOUNTING POLICIES	3. ACCOUNTING POLICIES Basis of Presentation and Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and in conformity with the condensing instructions on Form 10-Q and Rule 8-03 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto in the Company’s latest Annual Report filed with the SEC on Form 10-K as filed on June 14, 2023. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Robotic Assistance Devices, Inc., Robotic Assistance Devices Group , Inc, Robotic Assistance Devices Mobile, Inc., On the Move Experience, LLC and On the OMV Transports, LLC. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited consolidated financial statements reflect all adjustments, consisting of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of such statements. The results of operations for the nine months ended November 30, 2023 are not necessarily indicative of the results that may be expected for the entire year. Use of Estimates In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgements and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. The most significant estimates included in these consolidated financial statements are those associated with the assumptions used to value preferred stock and derivative liabilities. Concentrations Loans payable At November 30, 2023 there were $ 32,473,345 28,190,506 87 31,254,345 26,540,506 85 Cash The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents consist of cash on deposit with banks and money market instruments. The Company places its cash and cash equivalents with high-quality, U.S. financial institutions and, to date has not experienced losses on any of its balances. Accounts Receivable Accounts receivable are comprised of balances due from customers, net of estimated allowances for uncollectible accounts. In determining collectability, historical trends are evaluated, and specific customer issues are reviewed on a periodic basis to arrive at appropriate allowances. There was an allowance of $ 61,000 39,000 61 62 Device Parts Inventory Device parts inventory is stated at the lower of cost or net realizable value using the weighted average cost method. The Company records a valuation reserve for obsolete and slow-moving inventory, relying principally on specific identification of such inventory. The Company uses these device parts in the assembly of revenue earning devices (and demo devices) as well as research and development. Depending on use, the Company will transfer the parts to the corresponding asset or expense if used in research and development. A charge to income is taken when factors that would result in a need for an increase in the valuation, such as excess or obsolete inventory, are noted. As of November 30, 2023 and February 28, 2023 there was a valuation reserve of $ 195,000 195,000 Revenue Earning Devices Revenue earning devices are stated at cost. Depreciation is provided on a straight-line basis over the estimated useful life of 48 Fixed Assets Fixed assets are stated at cost. Depreciation is provided on the straight-line method based on the estimated useful lives of the respective assets which range from two to five years. Major repairs or improvements are capitalized. Minor replacements and maintenance and repairs which do not improve or extend asset lives are expensed currently. Fixed assets consisted of the following: Computer equipment and software 2 3 Office equipment 4 years Manufacturing equipment 7 years Warehouse equipment 5 years Tooling 2 years Demo Devices 4 years Vehicles 3 years Leasehold improvements 5 The Company periodically evaluates the fair value of fixed assets whenever events or changes in circumstances indicate that its carrying amounts may not be recoverable. Upon retirement or other disposition of fixed assets, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is recognized in income. Research and Development Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development Contingencies Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that it is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions. Sales of Future Revenues The Company has entered into transactions, as more fully described in footnote 8, in which it has received funding from investors in exchange for which it will make payments to those investors based on the level of sales of certain revenue categories, generally based on a percentage of sales for those certain revenues. The Company determines whether these agreements constitute sales of future revenues or are in substance debt based on the facts and circumstances of each agreement, with the following primary criteria determinative of whether the agreement constitutes a sale of future revenues or debt: ● Does the agreement purport, in substance, to be a sale ● Does the Company have continuing involvement in the generation of cash flows due the investor ● Is the transaction cancellable by either party through payment of a lump sum or other transfer of assets ● Is the investors rate of return is implicitly limited by the terms of the agreement ● Does the Company’s revenue for a reporting period underlying the agreement have only a minimal impact on the investor’s rate of return ● Does the investor have recourse relating to payments due In the event a transaction is determined to be a sale of future revenues, it is recorded as deferred revenue and amortized using the sum-of-the-revenue method. In the event a transaction is determined to be debt, it is recorded as debt and amortized using the effective interest method. As of the date of these financial statements, the Company has determined that all such agreements are debt. Revenue Recognition ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)” Revenue Recognition (Topic 605) four 58 two 41 Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. On December 22, 2017, the Tax Cuts and Jobs Act (“Tax Act”) was signed into law. ASC 740, Accounting for Income Taxes requires companies to recognize the effects of changes in tax laws and rates on deferred tax assets and liabilities and the retroactive effects of changes in tax laws in the period in which the new legislation is enacted. The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%. Leases Lease agreements are evaluated to determine if they are sales/finance leases meeting any of the following criteria at inception: (a) transfer of ownership of the underlying asset; (b) purchase option that is reasonably certain of being exercised; (c) the lease term is greater than a major part of the remaining estimated economic life of the underlying asset; or (d) if the present value of the sum of lease payments and any residual value guaranteed by the lessee that has not already been included in lease payments in accordance with ASC 842-10-30-5(f) equals or exceeds substantially all of the fair value of the underlying asset. If at its inception, a lease meets any of the four lease criteria above, the lease is classified by the Company as a sales/finance; and if none of the four criteria are met, the lease is classified by the Company as an operating lease. Operating lease payments are recognized as an expense in the income statement on a straight-line basis over the lease term, whereby an equal amount of rent expense is attributed to each period during the term of the lease, regardless of when actual payments are made. This generally results in rent expense in excess of cash payments during the early years of a lease and rent expense less than cash payments in the later years. The difference between rent expense recognized and actual rental payments is recorded as deferred rent and included in liabilities. Distinguishing Liabilities from Equity The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity. Our Chief Executive Officer/ Chairman holds sufficient shares of the Company’s voting preferred stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO/ Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company, without the need to call a general meeting of common shareholders of the Company. Initial Measurement The Company records its financial instruments classified as liability, temporary equity or permanent equity at issuance at the fair value, or cash received. Subsequent Measurement – Financial Instruments Classified as Liabilities The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in fair value of its financial instruments classified as liabilities are recorded as other income (expenses). Fair Value of Financial Instruments ASC Topic 820, Fair Value Measurements and Disclosures ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC Topic 820 are described as follows: ● Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date. ● Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means. ● Level 3 – Inputs that are unobservable for the asset or liability. Measured on a Recurring Basis The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell: Fair Value Measurement Using Amount at Level 1 Level 2 Level 3 November 30, 2023 Liabilities Incentive compensation plan payable- revaluation of equity awards payable in Series G shares $ 1,166,000 $ — $ — $ 1,166,000 February 28, 2023 Liabilities Incentive compensation plan payable- revaluation of equity awards payable in Series G shares $ 979,000 $ — $ — $ 979,000 The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, prepaid expenses and advances, accounts payable and accrued expenses, approximate their fair values because of the short maturity of these instruments. Earnings (Loss) per Share Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS give effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used to determine the number of shares assumed to be purchased from the exercise of stock options and/or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive. Basic loss per common share is computed based on the weighted average number of shares outstanding during the period. Diluted loss per share is computed in a manner similar to the basic loss per share, except the weighted-average number of shares outstanding is increased to include all common shares, including those with the potential to be issued by virtue of convertible debt and other such convertible instruments. Diluted loss per share contemplates a complete conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share. Recently Issued Accounting Pronouncements Recently Issued Accounting Standards Not Yet Adopted In August 2020, the FASB issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40) Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity

REVENUE FROM CONTRACTS WITH CUS

REVENUE FROM CONTRACTS WITH CUSTOMERS	9 Months Ended
	Nov. 30, 2023
Revenue from Contract with Customer [Abstract]
REVENUE FROM CONTRACTS WITH CUSTOMERS	4. REVENUE FROM CONTRACTS WITH CUSTOMERS Revenue is earned primarily from two sources: 1) direct sales of goods or services and 2) short-term rentals. Direct sales of goods or services are accounted for under Topic 606, and short-term rentals are accounted for under Topic 842 (which addresses lease accounting and was adopted on March 1, 2019). As disclosed in the revenue recognition section of Note 3 – Accounting Polices, the Company adopted Topic 606 in accordance with the effective date on March 1, 2018. Note 3 includes disclosures regarding the Company’s method of adoption and the impact on the Company’s financial statements. Revenue is recognized on direct sales of goods or services when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. After adopting Topic 842, also referred to above in Note 3, the Company is accounting for revenue earned from rental activities where an identified asset is transferred to the customer and the customer has the ability to control that asset. The Company recognizes revenue from its device rental activities when persuasive evidence of a contract exists, the performance obligations have been satisfied, the transaction price is fixed or determinable and collection is reasonably assured. Performance obligations associated with device rental transactions are satisfied over the rental period. Rental periods are short-term in nature. Therefore, the Company has elected to apply the practical expedient which eliminates the requirement to disclose information about remaining performance obligations. Payments are due from customers at the completion of the rental, except for customers with negotiated payment terms, generally net 30 days or less, which are invoiced and remain as accounts receivable until collected. The following table presents revenues from contracts with customers disaggregated by product/service: Three Months Three Months Nine Months Nine Months Device rental activities $ 416,062 $ 154,628 $ 997,754 $ 622,647 Direct sales of goods and services 180,918 247,771 370,797 432,393 Revenues $ 596,980 $ 402,399 $ 1,368,551 $ 1,055,040

LEASES

LEASES	9 Months Ended
	Nov. 30, 2023
Leases
LEASES	5. LEASES We lease certain warehouses, and office space. Leases with an initial term of 12 There is no lease renewal. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. Below is a summary of our lease assets and liabilities at November 30, 2023 and February 28, 2023. Leases Classification November 30, 2023 February 28, 2023 Assets Operating Operating Lease Assets $ 1,115,447 $ 1,208,440 Liabilities Current Operating Current Operating Lease Liability $ 229,016 $ 248,670 Noncurrent Operating Noncurrent Operating Lease Liabilities 881,816 950,541 Total lease liabilities $ 1,110,832 $ 1,199,211 Note: As most of our leases do not provide an implicit rate, we use our incremental borrowing rate of 10% which for the leases noted above was based on the information available at commencement date in determining the present value of lease payments. We compare against loans we obtain to acquire physical assets and not loans we obtain for financing. The loans we obtain for financing are generally at significantly higher rates and we believe that physical space or vehicle rental agreements are in line with physical asset financing agreements. CAM charges were not included in operating lease expense and were expensed in general and administrative expenses as incurred. Rent expense and operating lease cost was $ 64,081 189,164 61,005 194,653

REVENUE EARNING DEVICES

REVENUE EARNING DEVICES	9 Months Ended
	Nov. 30, 2023
Revenue Earning Devices
REVENUE EARNING DEVICES	6. REVENUE EARNING DEVICES Revenue earning devices consisted of the following: November 30, 2023 February 28, 2023 Revenue earning devices $ 3,321,560 $ 2,015,058 Less: Accumulated depreciation (1,209,664 ) (779,839 ) Total $ 2,111,896 $ 1,235,219 During the three and nine months ended November 30, 2023 the Company made total additions to revenue earning devices of $ 521,037 1,306,501 199,047 625,094 Depreciation expense was $ 165,370 429,825 54,418 241,957

FIXED ASSETS

FIXED ASSETS	9 Months Ended
	Nov. 30, 2023
Property, Plant and Equipment [Abstract]
FIXED ASSETS	7. FIXED ASSETS Fixed assets consisted of the following: November 30, 2023 February 28, 2023 Automobile $ 101,680 $ 101,680 Demo devices 184,438 69,010 Tooling 101,322 101,322 Machinery and equipment 8,825 8,825 Computer equipment 150,387 150,387 Office equipment 15,312 15,312 Furniture and fixtures 21,225 21,225 Warehouse equipment 17,076 14,561 Leasehold improvements 26,956 15,568 627,221 497,890 Less: Accumulated depreciation (326,921 ) (182,002 ) $ 300,300 $ 315,888 During the three months ended November 30, 2023, the Company made additions of $ 22,101 11,661 10,440 129,331 115,428 13,903 31,365 19,961 11,404 265,041 47,440 217,601 Depreciation expense was $ 50,393 144,921 38,437 90,686

DEFERRED VARIABLE PAYMENT OBLIG

DEFERRED VARIABLE PAYMENT OBLIGATION	9 Months Ended
	Nov. 30, 2023
Deferred Variable Payment Obligation
DEFERRED VARIABLE PAYMENT OBLIGATION	8. DEFERRED VARIABLE PAYMENT OBLIGATION On February 1, 2019 the Company entered into an agreement with an investor whereby the investor would pay up to $ 900,000 9 February 29, 2020 On May 9, 2019 the Company entered into two similar arrangements with two investors: (1) The investor would pay up to $ 400,000 4 400,000 (2) The investor would pay up to $ 50,000 1.11 50,000 These variable payments (Payments) are to be made 30 days after the end of each fiscal quarter. If the Payments would deplete RAD’s available cash by more than 30%, the Payments may be deferred for up to 12 months after the quarterly report at an interest rate of 6% per annum on the unpaid amount. In the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 30% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 30% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments. On November 18, 2019, the Company entered into another similar arrangement with the (February 1, 2019) investor above whereby the investor would advance up to $ 225,000 2.25 109,000 116,000 On December 30, 2019, the Company entered into another similar arrangement with a new investor whereby the investor would advance up to $100,000 in exchange for a perpetual 1.00 On April 22, 2020, the Company entered into another similar arrangement with the (first May 9, 2019) investor above whereby the investor would advance up to $ 100,000 1.00 On July 1, 2020, the Company entered into a similar agreement with the first investor whereby the investor would pay up to $ 800,000 2.75 If the Payments would deplete RAD’s available cash by more than 20%, the payment may be deferred. The investor had agreed to pay $100,000 per month over an 8 month period with the first payment due July 2020 and the final payment no later than February 28, 2021. As at August 31, 2020 the investor had fully funded the $800,000 commitment. On August 27, 2020, the Company and the first investor referred to above consolidated the three separate agreements of February 1, 2019 for $ 900,000 225,000 800,000 1,925,000 14.25 In summary of all agreements mentioned above if in the event that at least 10 The FMV cannot exceed 43.77% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments. As of March 1, 2021 as a result of the amendment with the first investor noted below. This aggregate asset disposition % was reduced from 43.77 % to 33.77%. The Payments first become payable on June 30, 2019 (unless otherwise indicated) based on the quarterly Revenues for the quarter ended May 31, 2019 and accrue every quarter thereafter. As of November 30, 2023, the Company has accrued $ 764,702 497,149 542,177 325,600 On March 1, 2021, the first investor referred to above whose aggregate investment is $ 1,925,000 1) The rate payment was reduced from 14.25 9.65 2) The asset disposition % (see below) was reduced from 31 21 In consideration for the above changes, the investor received 40 Series F Convertible Preferred Stock and a warrant to purchase 367 1.00 38 33,015,214 The Company retains total involvement in the generation of cash flows from these revenue streams that form the basis of the payments to be made to the investors under this agreement. Because of this, the Company has determined that the agreements constitute debt agreements. As of November 30, 2023, and February 28, 2023, the long-term balances other than Payments already owed is the cash received of $ 2,525,000 2,525,000 For both the three months and nine months ended November 30, 2023 and year ended February 28, 2023, the Company has received $ 0 2,525,000

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Nov. 30, 2023
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	9. RELATED PARTY TRANSACTIONS For both the three months ended November 30, 2023 and November 30, 2022 , the Company had no 299,286 206,516 222,754 183,625 12 108,000 108,000 12 28,267 15,660 Pursuant to the amended Employment Agreement with its Chief Executive Officer, for the three months and nine ended November 30, 2023, the Company accrued $ 62,000 138,000 187,000 362,500 1,000 1,166,000 979,000 During the three months ended November 30, 2023 and 2022, the Company was charged $ 526,723 794,460 During the nine months ended November 30, 2023 and 2022, the Company was charged $ 2,185,998 2,735,589

OTHER DEBT _ VEHICLE LOAN

OTHER DEBT – VEHICLE LOAN	9 Months Ended
	Nov. 30, 2023
Other Debt Vehicle Loan
OTHER DEBT – VEHICLE LOAN	10. OTHER DEBT – VEHICLE LOAN In December 2016, RAD entered into a vehicle loan for $ 47,704 5 1,019 47,661 5 October 24, 2022 923 0 21,907 3,257 21,578 18,766 5,515 13,251 16,944 38,522 38,522

LOANS PAYABLE

LOANS PAYABLE	9 Months Ended
	Nov. 30, 2023
Loans Payable
LOANS PAYABLE	11. LOANS PAYABLE Loans payable at November 30, 2023 consisted of the following: Annual Date Maturity Description Principal Interest Rate July 18, 2016 July 18, 2017 Promissory note (1) * $ 3,500 22% December 10, 2020 March 1, 2025 Promissory note (2) 3,921,168 12% December 10, 2020 March 1, 2025 Promissory note (3) 2,754,338 12% December 10, 2020 December 10, 2023 Promissory note (4) 165,605 12% December 14, 2020 December 14, 2023 Promissory note (5) 310,375 12% December 30, 2020 March 1, 2025 Promissory note (6) 350,000 12% January 1, 2021 March 1, 2025 Promissory note (7) 25,000 12% January 1, 2021 March 1, 2025 Promissory note (8) 145,000 12% January 14, 2021 March 1, 2025 Promissory note (9) 550,000 12% February 22, 20 March 1, 2025 Promissory note (10) 1,650,000 12% March 1, 2021 March 1, 2024 Promissory note (11) 6,000,000 12% June 8, 2021 June 8, 2024 Promissory note (12) 2,750,000 12% July 12, 2021 July 26, 2026 Promissory note (13) 3,803,360 7% September 14, 2021 September 14, 2024 Promissory note (14) 1,650,000 12% July 28, 2022 March 1, 2025 Promissory note (15) 170,000 15% August 30, 2022 August 30,2024 Promissory note (16) 3,000,000 15% September 7, 2022 March 1, 2025 Promissory note (17) 400,000 15% September 8, 2022 March 1, 2025 Promissory note (18) 475,000 15% October 13, 2022 March 1, 2025 Promissory note (19) 350,000 15% October 28, 2022 October 31, 2026 Promissory note (20) 400,000 15% November 9, 2022 October 31, 2026 Promissory note (20) 400,000 15% November 10, 2022 October 31, 2026 Promissory note (20) 400,000 15% November 15, 2022 October 31, 2026 Promissory note (20) 400,000 15% January 11, 2023 October 31, 2026 Promissory note (20) 400,000 15% February 6, 2023 October 31, 2026 Promissory note (20) 400,000 15% April 5. 2023 October 31, 2026 Promissory note (20) 400,000 15% April 20, 23 October 31, 2026 Promissory note (20) 400,000 15% May 11, 20 October 31, 2026 Promissory note (20) 400,000 15% October 27, 2023 October 31, 2026 Promissory note (20) 400,000 15% November 30, 2023 October 31, 2025 Purchase Agreement (21) ** — 35% $ 32,473,346 Less: current portion of loans payable (9,479,479 ) Less: discount on non-current loans payable (4,305,396 ) Non-current loans payable, net of discount $ 18,688,471 Current portion of loans payable $ 9,479,479 Less: discount on current portion of loans payable 1,129,801 Current portion of loans payable, net of discount $ 8,349,678 * In default ** Funds received December 1 , 2023, after reporting period. (1) This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender. (2) This promissory note was issued as part of a debt settlement whereby $ 2,683,357 1,237,811 3,921,168 3,921,168 .002 990,000 March 1, 2025 (3) This promissory note was issued as part of a debt settlement whereby $ 1,460,794 1,593,544 3,054,338 3,054,338 .002 550,000 100,000 300,000 2,754,338 March 1, 2025 (4) This promissory note was issued as part of a debt settlement whereby $ 103,180 62,425 165,605 165,605 80,000,000 .002 176,000 (5) This promissory note was issued as part of a debt settlement whereby $ 235,000 75,375 310,375 310,375 25,000,000 .002 182,500 (6) The note, with an original principal amount of $ 350,000 35,000 50,000,000 0.025 3 271,250 271,250 12,878 105,538 31,106 March 1, 2025 (7) This promissory note was issued as part of a debt settlement whereby $ 9,200 6,944 16,144 25,000 March 1, 2025 (8) This promissory note was issued as part of a debt settlement whereby $ 79,500 28,925 108,425 145,000 March 1, 2025 (9) The note, with an original principal amount of $ 550,000 250,000 50,000,000 0.025 3 380,174 380,174 16,718 129,906 50,493 March 1, 2025 (10) The note, with an original principal balance of $ 1,650,000 150,000 100,000,000 0.135 3 1,342,857 1,342,857 The maturity date was extended from February 22, 2022 to February 22, 2024 on February 28, 2022 in exchange for warrants to purchase 50,000,000 at an exercise price of $.0164 and a 3-year term. 950,000 82,499 462,320 426,061 March 1, 2025 (11) The unsecured note may be pre-payable at any time. Cash proceeds of $ 5,400,000 6,000,000 600,000 300,000,000 0.135 3 4,749,005 4,749,005 150,000,000 .0164 3 2,850,000 (12) The note, with an original principal balance of $ 2,750,000 50,000 170,000,000 0.064 3 2,035,033 2,035,033 85,000,000 .0164 3 1,615,000 199,482 530,181 264,037 (13) This loan, with an original principal balance of $ 4,000,160 27,000 81,000 (14) The note, with an original principal balance of $ 1,650,000 150,000 250,000,000 0.037 3 1,284,783 1,284,783 146,393 348,667 865,764 (15) Original $ 170,000 20,000 0 9,026 0 March 1, 2025 (16) A warrant holder exchanged 955,000,000 3,000,000 15 2,960,500 39,500 4,923 14,216 16,552 (17) Original $ 400,000 50,000 0 27,821 0 March 1, 2025 (18) Original $ 475,000 75,000 0 36,729 0 March 1, 2025 (19) Original $ 350,000 50,000 13,295 25,585 0 March 1, 2025 (20) On October 28, 2022 the Company entered into an loan facility with a lender for up to $ 4,000,000 400,000 50,000 3,274 7,613 340,411 400,000 50,000 3,234 7,510 340,929 400,000 50,000 2,991 6,891 343,990 400,000 50,000 3,295 7,665 340,151 400,000 50,000 3,355 7,821 339,368 400,000 50,000 3,231 7,503 340,923 400,000 50,000 3,335 6,608 339,637 400,000 50,000 2,723 4,930 347,290 400,000 50,000 0 0 398,983 400,000 50,000 2,044 2,044 309,715 (21) On November 30, 2023 , the Company entered into an agreement where the lender will buy pay the Company $ 350,000 thirteen future monthly payments of $36,750 commencing on April 30,2024 through to April 30, 2025 477,750 35

STOCKHOLDERS_ EQUITY (DEFICIT)

STOCKHOLDERS’ EQUITY (DEFICIT)	9 Months Ended
	Nov. 30, 2023
Equity [Abstract]
STOCKHOLDERS’ EQUITY (DEFICIT)	12. STOCKHOLDERS’ EQUITY (DEFICIT) Summary or Preferred Stock Activity No preferred stock activity during the period. Summary of Preferred Stock Warrant Activity Number of Series F Preferred Warrants Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at March 1, 2023 695 $1.00 10.00 Issued 244 1.00 9.88 Exercised — — — Forfeited and cancelled — — — Outstanding at November 30, 2023 939 $1.00 9.50 During the nine months ended November 30, 2023, as part of debt issuance the Company issued 244 Series F Preferred Warrants to a lender for a relative fair value of $ 1,209,206 Summary of Common Stock Activity The Company increased authorized common shares from 7,225,000,000 10,000,000,000 For the three months ended November 30, 2023, the Company issued 675,336,434 1,468,477 1,412,158 56,320 For the nine months ended November 30, 2023, the Company issued 1,859,901,628 7,841,466 7,527,190 314,276 6,500,000 44,460 83,200 38,640 12,100,000 The table below represent the common shares issued, issuable and outstanding at November 30, 2023 and February 28, 2023: Common shares November 30, 2023 February 28, 2023 Issued 7,715,143,227 5,836,641,599 Issuable — 12,100,000 Issued, issuable and outstanding 7,715,143,227 5,848,741,599 Summary of Common Stock Warrant Activity For the three months and nine months ended November 30, 2023 and November 30, 2022, the Company recorded a total of $ 47,462 0 150,896 0 Summary of Common Stock Warrant Activity Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at February 28, 2023 314,217,451 $0.114 1.95 Issued — — — Exercised — — — Forfeited and cancelled — — — Outstanding at November 30, 2023 314,217,451 $0.114 1.20 Summary of Common Stock Option Activity -Employee Stock Options Number of Options Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at February 28 , 2023 95,725,000 $0.02 4.75 Issued — — — Exercised — — — Forfeited, extinguished and cancelled (21,275,000 ) $0.02 (4.60) Outstanding at August 31, 2023 74,450,000 $0.02 4.00

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Nov. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	13. COMMITMENTS AND CONTINGENCIES Litigation Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s condensed consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions. The related legal costs are expensed as incurred. Operating Lease On December 18, 2020, the Company entered into a 15-month lease agreement for office space at 18009 Sky Park Circle Suite E 3,859 3,859 On March 10, 2021, the Company entered into a 10 year lease agreement for a manufacturing facility at 10800 Galaxie Avenue, Ferndale, Michigan, 48220, commencing on May 1, 2021 through to April 30, 2031 with a minimum base rent of $ 15,880 15,880 On September 30, 2021, the Company entered into a 3-year lease agreement for a vehicle commencing September 30, 2021 through to April 30, 2031 with a minimum base rent of $ 1,538 18,462 On January 28, 2022, the Company entered into a 2-year lease agreement for office space at 1516 E Edinger, Santa Ana, California, 92705, commencing on February 1, 2022 through to January 31, 2024 with a minimum base rent of $ 1,500 1,500 The Company’s leases are accounted for as operating leases. Rent expense and operating lease cost are recorded over the lease terms on a straight-line basis. Rent expense and operating lease cost was $ 64,081 189,164 61,005 194,653 Summary of rent expense and operating lease cost are recorded over the lease terms on a straight-line basis. Maturity of Lease Liabilities Operating November 30, 2024 $ 229,016 November 30, 2025 207,558 November 30, 2026 207,558 November 30, 2027 207,558 November 30, 2028 207,558 November 30, 2029 and after 501,599 Total lease payments 1,560,847 Less: Interest (450,015 ) Present value of lease liabilities $ 1,110,832

EARNINGS (LOSS) PER SHARE

EARNINGS (LOSS) PER SHARE	9 Months Ended
	Nov. 30, 2023
Earnings Per Share [Abstract]
EARNINGS (LOSS) PER SHARE	14. EARNINGS (LOSS) PER SHARE The net income (loss) per common share amounts were determined as follows: For the Three Months Ended For the Nine Months Ended November 30, November 30, 2023 2022 2023 2022 Numerator: Net income (loss) available to common shareholders $ (3,966,484 ) $ (4,085,660 ) $ (13,281,405 ) $ (12,930,211 ) Effect of common stock equivalents Add: interest expense on convertible debt — 22,438 — 27,863 Add: amortization of debt discount — 78,149 — 90,767 Add (less) loss (gain) on settlement of debt — — — (3,992 ) Add (less) loss (gain) on change of derivative liabilities — — — (3,595 ) Net income (loss) adjusted for common stock equivalents (3,966,484 ) (3,985,073 ) (13,281,405 ) (12,819,168 ) Denominator: Weighted average shares – basic 7,294,775,879 5,140,405,652 6,606,988,956 4,969,080,176 Net income (loss) per share – basic $ (0.00 ) $ (0.00 ) $ (0.00 ) $ (0.00 ) Dilutive effect of common stock equivalents: Convertible Debt — — — — Preferred shares — — — — Warrants — — — — — — — — Denominator: Weighted average shares – diluted 7,294,775,879 5,140,405,652 6,606,988,956 4,969,080,176 Net income (loss) per share – diluted $ (0.00 ) $ (0.00 ) $ (0.00 ) $ (0.00 ) The anti-dilutive shares of common stock equivalents for the three and nine months ended November 30, 2023 and 2022 were as follows: For the Three Months Ended For the Nine Months Ended November 30, November 30, 2023 2022 2023 2022 Convertible notes and accrued interest — 836,425,685 — 836,425,685 Convertible Series F Preferred Shares* 26,617,244,133 — 26,617,244,133 — Stock options and warrants 428,667,451 401,217,451 428,667,451 401,217,451 Total 27,045,911,584 1,237,643,136 27,045,911,584 1,237,643,136 * On August 23, 2021, the Company filed amended Series F preferred shares such that Series F preferred shares are not convertible into common stock by a holder until (A) August 23, 2023 or (B) the date on which such a conversion may be required for the purpose of (i) uplisting the Company to a new stock exchange, or (ii) selling more than 50% of the Company’s assets. Had these Series F preferred shares been convertible at November 30, 2023 and 2022 the dilutive effects would be as follows: Series F Preferred shares been convertible the dilutive effects would be as follows: For the Three and Nine Months Ended November 30, 2023 November 30, 2022 Convertible Series F Preferred Shares — 18,148,779,827

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Nov. 30, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	15. SUBSEQUENT EVENTS Subsequent to November 30, 2023 through to January 12, 2024: — The Company issued 639,550 1,523,258 62,980 1,460,278

ACCOUNTING POLICIES (Policies)

ACCOUNTING POLICIES (Policies)	9 Months Ended
	Nov. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation and Consolidation	Basis of Presentation and Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and in conformity with the condensing instructions on Form 10-Q and Rule 8-03 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto in the Company’s latest Annual Report filed with the SEC on Form 10-K as filed on June 14, 2023. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Robotic Assistance Devices, Inc., Robotic Assistance Devices Group , Inc, Robotic Assistance Devices Mobile, Inc., On the Move Experience, LLC and On the OMV Transports, LLC. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited consolidated financial statements reflect all adjustments, consisting of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of such statements. The results of operations for the nine months ended November 30, 2023 are not necessarily indicative of the results that may be expected for the entire year.
Use of Estimates	Use of Estimates In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgements and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. The most significant estimates included in these consolidated financial statements are those associated with the assumptions used to value preferred stock and derivative liabilities.
Concentrations	Concentrations Loans payable At November 30, 2023 there were $ 32,473,345 28,190,506 87 31,254,345 26,540,506 85
Cash	Cash The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents consist of cash on deposit with banks and money market instruments. The Company places its cash and cash equivalents with high-quality, U.S. financial institutions and, to date has not experienced losses on any of its balances.
Accounts Receivable	Accounts Receivable Accounts receivable are comprised of balances due from customers, net of estimated allowances for uncollectible accounts. In determining collectability, historical trends are evaluated, and specific customer issues are reviewed on a periodic basis to arrive at appropriate allowances. There was an allowance of $ 61,000 39,000 61 62
Device Parts Inventory	Device Parts Inventory Device parts inventory is stated at the lower of cost or net realizable value using the weighted average cost method. The Company records a valuation reserve for obsolete and slow-moving inventory, relying principally on specific identification of such inventory. The Company uses these device parts in the assembly of revenue earning devices (and demo devices) as well as research and development. Depending on use, the Company will transfer the parts to the corresponding asset or expense if used in research and development. A charge to income is taken when factors that would result in a need for an increase in the valuation, such as excess or obsolete inventory, are noted. As of November 30, 2023 and February 28, 2023 there was a valuation reserve of $ 195,000 195,000
Revenue Earning Devices	Revenue Earning Devices Revenue earning devices are stated at cost. Depreciation is provided on a straight-line basis over the estimated useful life of 48
Fixed Assets	Fixed Assets Fixed assets are stated at cost. Depreciation is provided on the straight-line method based on the estimated useful lives of the respective assets which range from two to five years. Major repairs or improvements are capitalized. Minor replacements and maintenance and repairs which do not improve or extend asset lives are expensed currently. Fixed assets consisted of the following: Computer equipment and software 2 3 Office equipment 4 years Manufacturing equipment 7 years Warehouse equipment 5 years Tooling 2 years Demo Devices 4 years Vehicles 3 years Leasehold improvements 5 The Company periodically evaluates the fair value of fixed assets whenever events or changes in circumstances indicate that its carrying amounts may not be recoverable. Upon retirement or other disposition of fixed assets, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is recognized in income.
Research and Development	Research and Development Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development
Contingencies	Contingencies Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that it is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.
Sales of Future Revenues	Sales of Future Revenues The Company has entered into transactions, as more fully described in footnote 8, in which it has received funding from investors in exchange for which it will make payments to those investors based on the level of sales of certain revenue categories, generally based on a percentage of sales for those certain revenues. The Company determines whether these agreements constitute sales of future revenues or are in substance debt based on the facts and circumstances of each agreement, with the following primary criteria determinative of whether the agreement constitutes a sale of future revenues or debt: ● Does the agreement purport, in substance, to be a sale ● Does the Company have continuing involvement in the generation of cash flows due the investor ● Is the transaction cancellable by either party through payment of a lump sum or other transfer of assets ● Is the investors rate of return is implicitly limited by the terms of the agreement ● Does the Company’s revenue for a reporting period underlying the agreement have only a minimal impact on the investor’s rate of return ● Does the investor have recourse relating to payments due In the event a transaction is determined to be a sale of future revenues, it is recorded as deferred revenue and amortized using the sum-of-the-revenue method. In the event a transaction is determined to be debt, it is recorded as debt and amortized using the effective interest method. As of the date of these financial statements, the Company has determined that all such agreements are debt.
Revenue Recognition	Revenue Recognition ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)” Revenue Recognition (Topic 605) four 58 two 41
Income Taxes	Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. On December 22, 2017, the Tax Cuts and Jobs Act (“Tax Act”) was signed into law. ASC 740, Accounting for Income Taxes requires companies to recognize the effects of changes in tax laws and rates on deferred tax assets and liabilities and the retroactive effects of changes in tax laws in the period in which the new legislation is enacted. The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%.
Leases	Leases Lease agreements are evaluated to determine if they are sales/finance leases meeting any of the following criteria at inception: (a) transfer of ownership of the underlying asset; (b) purchase option that is reasonably certain of being exercised; (c) the lease term is greater than a major part of the remaining estimated economic life of the underlying asset; or (d) if the present value of the sum of lease payments and any residual value guaranteed by the lessee that has not already been included in lease payments in accordance with ASC 842-10-30-5(f) equals or exceeds substantially all of the fair value of the underlying asset. If at its inception, a lease meets any of the four lease criteria above, the lease is classified by the Company as a sales/finance; and if none of the four criteria are met, the lease is classified by the Company as an operating lease. Operating lease payments are recognized as an expense in the income statement on a straight-line basis over the lease term, whereby an equal amount of rent expense is attributed to each period during the term of the lease, regardless of when actual payments are made. This generally results in rent expense in excess of cash payments during the early years of a lease and rent expense less than cash payments in the later years. The difference between rent expense recognized and actual rental payments is recorded as deferred rent and included in liabilities.
Distinguishing Liabilities from Equity	Distinguishing Liabilities from Equity The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity. Our Chief Executive Officer/ Chairman holds sufficient shares of the Company’s voting preferred stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO/ Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company, without the need to call a general meeting of common shareholders of the Company. Initial Measurement The Company records its financial instruments classified as liability, temporary equity or permanent equity at issuance at the fair value, or cash received. Subsequent Measurement – Financial Instruments Classified as Liabilities The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in fair value of its financial instruments classified as liabilities are recorded as other income (expenses).
Fair Value of Financial Instruments	Fair Value of Financial Instruments ASC Topic 820, Fair Value Measurements and Disclosures ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC Topic 820 are described as follows: ● Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date. ● Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means. ● Level 3 – Inputs that are unobservable for the asset or liability. Measured on a Recurring Basis The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell: Fair Value Measurement Using Amount at Level 1 Level 2 Level 3 November 30, 2023 Liabilities Incentive compensation plan payable- revaluation of equity awards payable in Series G shares $ 1,166,000 $ — $ — $ 1,166,000 February 28, 2023 Liabilities Incentive compensation plan payable- revaluation of equity awards payable in Series G shares $ 979,000 $ — $ — $ 979,000 The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, prepaid expenses and advances, accounts payable and accrued expenses, approximate their fair values because of the short maturity of these instruments.
Earnings (Loss) per Share	Earnings (Loss) per Share Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS give effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used to determine the number of shares assumed to be purchased from the exercise of stock options and/or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive. Basic loss per common share is computed based on the weighted average number of shares outstanding during the period. Diluted loss per share is computed in a manner similar to the basic loss per share, except the weighted-average number of shares outstanding is increased to include all common shares, including those with the potential to be issued by virtue of convertible debt and other such convertible instruments. Diluted loss per share contemplates a complete conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements Recently Issued Accounting Standards Not Yet Adopted In August 2020, the FASB issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40) Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity

ACCOUNTING POLICIES (Tables)

ACCOUNTING POLICIES (Tables)	9 Months Ended
	Nov. 30, 2023
Accounting Policies [Abstract]
Fixed assets consisted of the following:	Fixed assets consisted of the following: Computer equipment and software 2 3 Office equipment 4 years Manufacturing equipment 7 years Warehouse equipment 5 years Tooling 2 years Demo Devices 4 years Vehicles 3 years Leasehold improvements 5
The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell:	The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell: Fair Value Measurement Using Amount at Level 1 Level 2 Level 3 November 30, 2023 Liabilities Incentive compensation plan payable- revaluation of equity awards payable in Series G shares $ 1,166,000 $ — $ — $ 1,166,000 February 28, 2023 Liabilities Incentive compensation plan payable- revaluation of equity awards payable in Series G shares $ 979,000 $ — $ — $ 979,000

REVENUE FROM CONTRACTS WITH C_2

REVENUE FROM CONTRACTS WITH CUSTOMERS (Tables)	9 Months Ended
	Nov. 30, 2023
Revenue from Contract with Customer [Abstract]
The following table presents revenues from contracts with customers disaggregated by product/service:	The following table presents revenues from contracts with customers disaggregated by product/service: Three Months Three Months Nine Months Nine Months Device rental activities $ 416,062 $ 154,628 $ 997,754 $ 622,647 Direct sales of goods and services 180,918 247,771 370,797 432,393 Revenues $ 596,980 $ 402,399 $ 1,368,551 $ 1,055,040

LEASES (Tables)

LEASES (Tables)	9 Months Ended
	Nov. 30, 2023
Leases
Below is a summary of our lease assets and liabilities at November 30, 2023 and February 28, 2023.	Below is a summary of our lease assets and liabilities at November 30, 2023 and February 28, 2023. Leases Classification November 30, 2023 February 28, 2023 Assets Operating Operating Lease Assets $ 1,115,447 $ 1,208,440 Liabilities Current Operating Current Operating Lease Liability $ 229,016 $ 248,670 Noncurrent Operating Noncurrent Operating Lease Liabilities 881,816 950,541 Total lease liabilities $ 1,110,832 $ 1,199,211

REVENUE EARNING DEVICES (Tables

REVENUE EARNING DEVICES (Tables)	9 Months Ended
	Nov. 30, 2023
Revenue Earning Devices
Revenue earning devices consisted of the following:	Revenue earning devices consisted of the following: November 30, 2023 February 28, 2023 Revenue earning devices $ 3,321,560 $ 2,015,058 Less: Accumulated depreciation (1,209,664 ) (779,839 ) Total $ 2,111,896 $ 1,235,219

FIXED ASSETS (Tables)

FIXED ASSETS (Tables)	9 Months Ended
	Nov. 30, 2023
Property, Plant and Equipment [Abstract]
Fixed assets consisted of the following:	Fixed assets consisted of the following: November 30, 2023 February 28, 2023 Automobile $ 101,680 $ 101,680 Demo devices 184,438 69,010 Tooling 101,322 101,322 Machinery and equipment 8,825 8,825 Computer equipment 150,387 150,387 Office equipment 15,312 15,312 Furniture and fixtures 21,225 21,225 Warehouse equipment 17,076 14,561 Leasehold improvements 26,956 15,568 627,221 497,890 Less: Accumulated depreciation (326,921 ) (182,002 ) $ 300,300 $ 315,888

LOANS PAYABLE (Tables)

LOANS PAYABLE (Tables)	9 Months Ended
	Nov. 30, 2023
Loans Payable
Loans payable at November 30, 2023 consisted of the following:	Loans payable at November 30, 2023 consisted of the following: Annual Date Maturity Description Principal Interest Rate July 18, 2016 July 18, 2017 Promissory note (1) * $ 3,500 22% December 10, 2020 March 1, 2025 Promissory note (2) 3,921,168 12% December 10, 2020 March 1, 2025 Promissory note (3) 2,754,338 12% December 10, 2020 December 10, 2023 Promissory note (4) 165,605 12% December 14, 2020 December 14, 2023 Promissory note (5) 310,375 12% December 30, 2020 March 1, 2025 Promissory note (6) 350,000 12% January 1, 2021 March 1, 2025 Promissory note (7) 25,000 12% January 1, 2021 March 1, 2025 Promissory note (8) 145,000 12% January 14, 2021 March 1, 2025 Promissory note (9) 550,000 12% February 22, 20 March 1, 2025 Promissory note (10) 1,650,000 12% March 1, 2021 March 1, 2024 Promissory note (11) 6,000,000 12% June 8, 2021 June 8, 2024 Promissory note (12) 2,750,000 12% July 12, 2021 July 26, 2026 Promissory note (13) 3,803,360 7% September 14, 2021 September 14, 2024 Promissory note (14) 1,650,000 12% July 28, 2022 March 1, 2025 Promissory note (15) 170,000 15% August 30, 2022 August 30,2024 Promissory note (16) 3,000,000 15% September 7, 2022 March 1, 2025 Promissory note (17) 400,000 15% September 8, 2022 March 1, 2025 Promissory note (18) 475,000 15% October 13, 2022 March 1, 2025 Promissory note (19) 350,000 15% October 28, 2022 October 31, 2026 Promissory note (20) 400,000 15% November 9, 2022 October 31, 2026 Promissory note (20) 400,000 15% November 10, 2022 October 31, 2026 Promissory note (20) 400,000 15% November 15, 2022 October 31, 2026 Promissory note (20) 400,000 15% January 11, 2023 October 31, 2026 Promissory note (20) 400,000 15% February 6, 2023 October 31, 2026 Promissory note (20) 400,000 15% April 5. 2023 October 31, 2026 Promissory note (20) 400,000 15% April 20, 23 October 31, 2026 Promissory note (20) 400,000 15% May 11, 20 October 31, 2026 Promissory note (20) 400,000 15% October 27, 2023 October 31, 2026 Promissory note (20) 400,000 15% November 30, 2023 October 31, 2025 Purchase Agreement (21) ** — 35% $ 32,473,346 Less: current portion of loans payable (9,479,479 ) Less: discount on non-current loans payable (4,305,396 ) Non-current loans payable, net of discount $ 18,688,471 Current portion of loans payable $ 9,479,479 Less: discount on current portion of loans payable 1,129,801 Current portion of loans payable, net of discount $ 8,349,678 * In default ** Funds received December 1 , 2023, after reporting period. (1) This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender. (2) This promissory note was issued as part of a debt settlement whereby $ 2,683,357 1,237,811 3,921,168 3,921,168 .002 990,000 March 1, 2025 (3) This promissory note was issued as part of a debt settlement whereby $ 1,460,794 1,593,544 3,054,338 3,054,338 .002 550,000 100,000 300,000 2,754,338 March 1, 2025 (4) This promissory note was issued as part of a debt settlement whereby $ 103,180 62,425 165,605 165,605 80,000,000 .002 176,000 (5) This promissory note was issued as part of a debt settlement whereby $ 235,000 75,375 310,375 310,375 25,000,000 .002 182,500 (6) The note, with an original principal amount of $ 350,000 35,000 50,000,000 0.025 3 271,250 271,250 12,878 105,538 31,106 March 1, 2025 (7) This promissory note was issued as part of a debt settlement whereby $ 9,200 6,944 16,144 25,000 March 1, 2025 (8) This promissory note was issued as part of a debt settlement whereby $ 79,500 28,925 108,425 145,000 March 1, 2025 (9) The note, with an original principal amount of $ 550,000 250,000 50,000,000 0.025 3 380,174 380,174 16,718 129,906 50,493 March 1, 2025 (10) The note, with an original principal balance of $ 1,650,000 150,000 100,000,000 0.135 3 1,342,857 1,342,857 The maturity date was extended from February 22, 2022 to February 22, 2024 on February 28, 2022 in exchange for warrants to purchase 50,000,000 at an exercise price of $.0164 and a 3-year term. 950,000 82,499 462,320 426,061 March 1, 2025 (11) The unsecured note may be pre-payable at any time. Cash proceeds of $ 5,400,000 6,000,000 600,000 300,000,000 0.135 3 4,749,005 4,749,005 150,000,000 .0164 3 2,850,000 (12) The note, with an original principal balance of $ 2,750,000 50,000 170,000,000 0.064 3 2,035,033 2,035,033 85,000,000 .0164 3 1,615,000 199,482 530,181 264,037 (13) This loan, with an original principal balance of $ 4,000,160 27,000 81,000 (14) The note, with an original principal balance of $ 1,650,000 150,000 250,000,000 0.037 3 1,284,783 1,284,783 146,393 348,667 865,764 (15) Original $ 170,000 20,000 0 9,026 0 March 1, 2025 (16) A warrant holder exchanged 955,000,000 3,000,000 15 2,960,500 39,500 4,923 14,216 16,552 (17) Original $ 400,000 50,000 0 27,821 0 March 1, 2025 (18) Original $ 475,000 75,000 0 36,729 0 March 1, 2025 (19) Original $ 350,000 50,000 13,295 25,585 0 March 1, 2025 (20) On October 28, 2022 the Company entered into an loan facility with a lender for up to $ 4,000,000 400,000 50,000 3,274 7,613 340,411 400,000 50,000 3,234 7,510 340,929 400,000 50,000 2,991 6,891 343,990 400,000 50,000 3,295 7,665 340,151 400,000 50,000 3,355 7,821 339,368 400,000 50,000 3,231 7,503 340,923 400,000 50,000 3,335 6,608 339,637 400,000 50,000 2,723 4,930 347,290 400,000 50,000 0 0 398,983 400,000 50,000 2,044 2,044 309,715 (21) On November 30, 2023 , the Company entered into an agreement where the lender will buy pay the Company $ 350,000 thirteen future monthly payments of $36,750 commencing on April 30,2024 through to April 30, 2025 477,750 35

STOCKHOLDERS_ EQUITY (DEFICIT)

STOCKHOLDERS’ EQUITY (DEFICIT) (Tables)	9 Months Ended
	Nov. 30, 2023
Equity [Abstract]
Summary of Preferred Stock Warrant Activity	Summary of Preferred Stock Warrant Activity Number of Series F Preferred Warrants Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at March 1, 2023 695 $1.00 10.00 Issued 244 1.00 9.88 Exercised — — — Forfeited and cancelled — — — Outstanding at November 30, 2023 939 $1.00 9.50
The table below represent the common shares issued, issuable and outstanding at November 30, 2023 and February 28, 2023:	The table below represent the common shares issued, issuable and outstanding at November 30, 2023 and February 28, 2023: Common shares November 30, 2023 February 28, 2023 Issued 7,715,143,227 5,836,641,599 Issuable — 12,100,000 Issued, issuable and outstanding 7,715,143,227 5,848,741,599
Summary of Common Stock Warrant Activity	Summary of Common Stock Warrant Activity Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at February 28, 2023 314,217,451 $0.114 1.95 Issued — — — Exercised — — — Forfeited and cancelled — — — Outstanding at November 30, 2023 314,217,451 $0.114 1.20
Summary of Common Stock Option Activity -Employee Stock Options	Summary of Common Stock Option Activity -Employee Stock Options Number of Options Weighted Average Exercise Price Weighted Average Remaining Years Outstanding at February 28 , 2023 95,725,000 $0.02 4.75 Issued — — — Exercised — — — Forfeited, extinguished and cancelled (21,275,000 ) $0.02 (4.60) Outstanding at August 31, 2023 74,450,000 $0.02 4.00

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	9 Months Ended
	Nov. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Summary of rent expense and operating lease cost are recorded over the lease terms on a straight-line basis.	Summary of rent expense and operating lease cost are recorded over the lease terms on a straight-line basis. Maturity of Lease Liabilities Operating November 30, 2024 $ 229,016 November 30, 2025 207,558 November 30, 2026 207,558 November 30, 2027 207,558 November 30, 2028 207,558 November 30, 2029 and after 501,599 Total lease payments 1,560,847 Less: Interest (450,015 ) Present value of lease liabilities $ 1,110,832

EARNINGS (LOSS) PER SHARE (Tabl

EARNINGS (LOSS) PER SHARE (Tables)	9 Months Ended
	Nov. 30, 2023
Earnings Per Share [Abstract]
The net income (loss) per common share amounts were determined as follows:	The net income (loss) per common share amounts were determined as follows: For the Three Months Ended For the Nine Months Ended November 30, November 30, 2023 2022 2023 2022 Numerator: Net income (loss) available to common shareholders $ (3,966,484 ) $ (4,085,660 ) $ (13,281,405 ) $ (12,930,211 ) Effect of common stock equivalents Add: interest expense on convertible debt — 22,438 — 27,863 Add: amortization of debt discount — 78,149 — 90,767 Add (less) loss (gain) on settlement of debt — — — (3,992 ) Add (less) loss (gain) on change of derivative liabilities — — — (3,595 ) Net income (loss) adjusted for common stock equivalents (3,966,484 ) (3,985,073 ) (13,281,405 ) (12,819,168 ) Denominator: Weighted average shares – basic 7,294,775,879 5,140,405,652 6,606,988,956 4,969,080,176 Net income (loss) per share – basic $ (0.00 ) $ (0.00 ) $ (0.00 ) $ (0.00 ) Dilutive effect of common stock equivalents: Convertible Debt — — — — Preferred shares — — — — Warrants — — — — — — — — Denominator: Weighted average shares – diluted 7,294,775,879 5,140,405,652 6,606,988,956 4,969,080,176 Net income (loss) per share – diluted $ (0.00 ) $ (0.00 ) $ (0.00 ) $ (0.00 )
The anti-dilutive shares of common stock equivalents for the three and nine months ended November 30, 2023 and 2022 were as follows:	The anti-dilutive shares of common stock equivalents for the three and nine months ended November 30, 2023 and 2022 were as follows: For the Three Months Ended For the Nine Months Ended November 30, November 30, 2023 2022 2023 2022 Convertible notes and accrued interest — 836,425,685 — 836,425,685 Convertible Series F Preferred Shares* 26,617,244,133 — 26,617,244,133 — Stock options and warrants 428,667,451 401,217,451 428,667,451 401,217,451 Total 27,045,911,584 1,237,643,136 27,045,911,584 1,237,643,136 * On August 23, 2021, the Company filed amended Series F preferred shares such that Series F preferred shares are not convertible into common stock by a holder until (A) August 23, 2023 or (B) the date on which such a conversion may be required for the purpose of (i) uplisting the Company to a new stock exchange, or (ii) selling more than 50% of the Company’s assets. Had these Series F preferred shares been convertible at November 30, 2023 and 2022 the dilutive effects would be as follows:
Series F Preferred shares been convertible the dilutive effects would be as follows:	Series F Preferred shares been convertible the dilutive effects would be as follows: For the Three and Nine Months Ended November 30, 2023 November 30, 2022 Convertible Series F Preferred Shares — 18,148,779,827

GENERAL INFORMATION (Details Na

GENERAL INFORMATION (Details Narrative) - shares	Aug. 28, 2017	Nov. 30, 2023	Feb. 28, 2023	Jul. 25, 2017
Restructuring Cost and Reserve [Line Items]
Common stock, issued		7,715,143,227	5,848,741,599
Robotic Assistance Devices LLC [Member]
Restructuring Cost and Reserve [Line Items]
Common stock, issued				10,000
Robotic Assistance Devices LLC [Member] | Series E Preferred Stock [Member]
Restructuring Cost and Reserve [Line Items]
Number of shares isuued under acquisition	3,350,000
Robotic Assistance Devices LLC [Member] | Series F Preferred Stock [Member]
Restructuring Cost and Reserve [Line Items]
Number of shares isuued under acquisition	2,450

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative) - USD ($)		1 Months Ended	9 Months Ended
	Nov. 30, 2023	Mar. 31, 2023	Nov. 30, 2023
Cash flow from operating activities			$ 9,378,427
Accumulated deficit	$ 125,535,116		125,535,116
Working capital	12,944,810		12,944,810
Additional issuance costs	7,500,000
Issuance debt	1,400,000		1,400,000
Additional issuance costs	$ 1,500,000
Minimum [Member]
Other cost cutting management estimates			200,000
Maximum [Member]
Other cost cutting management estimates			$ 300,000
Common Stock [Member]
Purchase of common stock		$ 12,500,000

Fixed assets consisted of the f

Fixed assets consisted of the following: (Details) - USD ($)	Nov. 30, 2023	Feb. 28, 2023
Property, Plant and Equipment [Line Items]
Gross	$ 627,221	$ 497,890
Less: accumulated depreciation	(326,921)	(182,002)
Fixed assets, net of accumulated depreciation	$ 300,300	315,888	[1]
Computer Equipment and Software [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	2 years
Computer Equipment and Software [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	3 years
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	4 years
Gross	$ 15,312	15,312
Manufacturing Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	7 years
Warehouse Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	5 years
Gross	$ 17,076	14,561
Tooling [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	2 years
Demo Devices [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	4 years
Gross	$ 184,438	69,010
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	3 years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	5 years
Gross	$ 26,956	15,568
Automobiles [Member]
Property, Plant and Equipment [Line Items]
Gross	101,680	101,680
Tools, Dies and Molds [Member]
Property, Plant and Equipment [Line Items]
Gross	101,322	101,322
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Gross	8,825	8,825
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Gross	150,387	150,387
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Gross	$ 21,225	$ 21,225
[1]Derived from audited information

The following table presents in

The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell: (Details) - USD ($)	Nov. 30, 2023	Feb. 28, 2023
Platform Operator, Crypto-Asset [Line Items]
Incentive compensation plan payable revaluation of equity awards payable in Series G shares	$ 1,166,000	$ 979,000
Fair Value, Inputs, Level 1 [Member]
Platform Operator, Crypto-Asset [Line Items]
Incentive compensation plan payable revaluation of equity awards payable in Series G shares
Fair Value, Inputs, Level 2 [Member]
Platform Operator, Crypto-Asset [Line Items]
Incentive compensation plan payable revaluation of equity awards payable in Series G shares
Fair Value, Inputs, Level 3 [Member]
Platform Operator, Crypto-Asset [Line Items]
Incentive compensation plan payable revaluation of equity awards payable in Series G shares	$ 1,166,000	$ 979,000

ACCOUNTING POLICIES (Details Na

ACCOUNTING POLICIES (Details Narrative)	3 Months Ended		9 Months Ended	12 Months Ended
	Nov. 30, 2023 USD ($) Number	Nov. 30, 2022 Number	Nov. 30, 2023 USD ($) Number	Feb. 28, 2023 USD ($)
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Loans payable	$ 32,473,345		$ 32,473,345	$ 31,254,345
Accounts receivable, net	$ 505,438		505,438	265,024	[1]
Percentage of accounts receivable	61%	62%
Inventory valuation reserves	$ 195,000		$ 195,000	195,000
Depreciation life	48 months		48 months
Percentage of revenue	58%	41%	58%
Description of deferred tax assets and liabilities			The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%.
Four Customer [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of customers | Number	4		4
Two Customer [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of customers | Number		2
Controller [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Loans additions			$ 28,190,506	$ 26,540,506
Loans percentage	87%		87%	85%
[1]Derived from audited information

The following table presents re

The following table presents revenues from contracts with customers disaggregated by product/service: (Details) - USD ($)	3 Months Ended		9 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2023	Nov. 30, 2022
Revenue from Contract with Customer [Abstract]
Device rental activities	$ 416,062	$ 154,628	$ 997,754	$ 622,647
Direct sales of goods and services	180,918	247,771	370,797	432,393
Revenues	$ 596,980	$ 402,399	$ 1,368,551	$ 1,055,040

Below is a summary of our lease

Below is a summary of our lease assets and liabilities at November 30, 2023 and February 28, 2023. (Details) - USD ($)	Nov. 30, 2023	Feb. 28, 2023
Leases
Operating lease assets	$ 1,115,447	$ 1,208,440
Current operating lease liability	229,016	248,670	[1]
Noncurrent operating lease liabilities	881,816	950,541	[1]
Total lease liabilities	$ 1,110,832	$ 1,199,211
[1]Derived from audited information

LEASES (Details Narrative)

LEASES (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2023	Nov. 30, 2022
Leases
Weighted average remaining lease term	12 months		12 months
Rent	$ 64,081	$ 61,005	$ 189,164	$ 194,653
Operating lease cost	$ 64,081	$ 61,005	$ 189,164	$ 194,653

Revenue earning devices consist

Revenue earning devices consisted of the following: (Details) - USD ($)	Nov. 30, 2023	Feb. 28, 2023
Revenue Earning Devices
Revenue earning devices	$ 3,321,560	$ 2,015,058
Less: Accumulated depreciation	(1,209,664)	(779,839)
Total	$ 2,111,896	$ 1,235,219

REVENUE EARNING DEVICES (Detail

REVENUE EARNING DEVICES (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2023	Nov. 30, 2022
Restructuring Cost and Reserve [Line Items]
Revenue earning	$ 596,980	$ 402,399	$ 1,368,551	$ 1,055,040
Depreciation expense	215,763	92,855	574,746	332,643
Robotic Assistance Devices LLC [Member]
Restructuring Cost and Reserve [Line Items]
Revenue earning	521,037	199,047	1,306,501	625,094
Depreciation expense	$ 165,370	$ 54,418	$ 429,825	$ 241,957

FIXED ASSETS (Details Narrative

FIXED ASSETS (Details Narrative) - Robotic Assistance Devices LLC [Member] - USD ($)	3 Months Ended		9 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2023	Nov. 30, 2022
Restructuring Cost and Reserve [Line Items]
Additions to fixed assets	$ 22,101	$ 31,365	$ 129,331	$ 265,041
Assets transfers from inventory	11,661	19,961	115,428	47,440
Remaining additions to fixed assets	10,440	11,404	13,903	217,601
Depreciation expense	$ 50,393	$ 38,437	$ 144,921	$ 90,686

DEFERRED VARIABLE PAYMENT OBL_2

DEFERRED VARIABLE PAYMENT OBLIGATION (Details Narrative) - USD ($)

3 Months Ended

6 Months Ended

9 Months Ended

12 Months Ended

Mar. 03, 2021

Aug. 27, 2020

Jul. 01, 2020

Apr. 22, 2020

Feb. 29, 2020

Dec. 30, 2019

Nov. 18, 2019

May 09, 2019

Feb. 01, 2019

May 31, 2021

Aug. 27, 2021

Nov. 30, 2023

Feb. 28, 2023

Principal amount

$ 32,473,346

Accrued payment

764,702

$ 542,177

Default on payments

497,149

325,600

Aggregate investment

$ 1,925,000

Total payment obligation

$ 2,525,000

2,525,000

[1]

Payment receive

0

Investor [Member]

Maximum amount of debt

$ 1,925,000

$ 800,000

$ 100,000

$ 900,000

Percentage of exchange rate

14.25%

2.75%

1%

1%

9%

Debt instrument, date of first required payment

Feb. 29, 2020

Description of variable payments terms

These variable payments (Payments) are to be made 30 days after the end of each fiscal quarter. If the Payments would deplete RAD’s available cash by more than 30%, the Payments may be deferred for up to 12 months after the quarterly report at an interest rate of 6% per annum on the unpaid amount.

Description of disposition price

The FMV cannot exceed 43.77% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments. As of March 1, 2021 as a result of the amendment with the first investor noted below. This aggregate asset disposition % was reduced from 43.77 % to 33.77%.

The FMV cannot exceed 30% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments.

Principal amount

$ 109,000

$ 225,000

Advance amount

116,000

Investor [Member] | Series F Preferred Stock [Member]

Purchase of warrant

367

38

Exercise price

$ 1

Fair value of warrants

$ 33,015,214

Investor [Member] | Maximum [Member]

Percentage of exchange rate

14.25%

Percentage of total asset disposition price

31%

Investor [Member] | Minimum [Member]

Percentage of exchange rate

9.65%

Percentage of total asset disposition price

21%

Investor [Member] | Agreement [Member]

Maximum amount of debt

$ 900,000

Investor [Member] | Agreement One [Member]

Maximum amount of debt

225,000

Investor [Member] | Ageement Two [Member]

Maximum amount of debt

$ 800,000

Investor One [Member]

Maximum amount of debt

400,000

$ 400,000

Percentage of exchange rate

4%

Investor Two [Member]

Maximum amount of debt

$ 50,000

$ 50,000

Percentage of exchange rate

1.11%

Investor Four [Member]

Percentage of exchange rate

2.25%

Investor Five [Member]

Description of variable payments terms

If the Payments would deplete RAD’s available cash by more than 20%, the payment may be deferred. The investor had agreed to pay $100,000 per month over an 8 month period with the first payment due July 2020 and the final payment no later than February 28, 2021. As at August 31, 2020 the investor had fully funded the $800,000 commitment.

Investor Eight [Member]

Percentage of assets sold

10%

Investor Eight [Member]

Total payment obligation

$ 2,525,000

2,525,000

Deferred payment obligation

$ 2,525,000

$ 2,525,000

[1]Derived from audited information

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	3 Months Ended			9 Months Ended		12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Aug. 31, 2022	Nov. 30, 2023	Nov. 30, 2022	Feb. 28, 2023
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Net borrowings on loan payable - related party				$ 0	$ 0
Loan payable - related party	$ 299,286			299,286		$ 206,516
Balance due to related party	222,754			222,754		$ 108,000
Interest Expense	1,581,533	$ 1,271,158		$ 4,940,965	3,448,208
Percentage of interest expense due to related party				12%		12%
Deferred salary payable to related party						$ 108,000
Interest accrued related party				$ 28,267		15,660
Consulting fees for research and development	$ 526,723	$ 794,460		$ 2,185,998	2,735,589
Incentives Compensation Plan [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Share price	$ 1,000			$ 1,000
Employment Agreement [Member] | Incentives Compensation Plan [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Incentive compensation plan payable	$ 1,166,000			$ 1,166,000		$ 979,000
Chief Executive Officer [Member] | Employment Agreement [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Incentive compensation plan payable	$ 62,000		$ 138,000	$ 187,000	$ 362,500

OTHER DEBT _ VEHICLE LOAN (Deta

OTHER DEBT – VEHICLE LOAN (Details Narrative) - USD ($)	1 Months Ended		9 Months Ended
	Nov. 30, 2017	Dec. 31, 2016	Nov. 30, 2023	Feb. 28, 2023	Feb. 28, 2022	Feb. 28, 2021	Feb. 28, 2020	Feb. 28, 2019
Restructuring Cost and Reserve [Line Items]
Vehicle loan secured by automobile			$ 32,473,346
Principal repayments of loan					$ 0	$ 0
Proceeds of disposal of vehicle offset against vehicle loan			18,766
Remaining asset value			5,515
Reclassification of fixed assets to vehicle for disposal			13,251
Robotic Assistance Devices LLC [Member] | Secured Debt [Member]
Restructuring Cost and Reserve [Line Items]
Vehicle loan secured by automobile	$ 47,661	$ 47,704
Term of debt	5 years	5 years
Payment of debt interest and principal	$ 923	$ 1,019
Maturity date	Oct. 24, 2022
Outstanding balance of the loan								$ 21,907
Loss on sale of vehicle			3,257
Current portion vehicle loan							$ 21,578
Long-term vehicle loan					$ 16,944	$ 16,944
Total vehicle loan			$ 38,522	$ 38,522

Loans payable at November 30, 2

Loans payable at November 30, 2023 consisted of the following: (Details) - USD ($)													3 Months Ended			9 Months Ended				12 Months Ended
		Oct. 27, 2023	May 11, 2023	Apr. 20, 2023	Apr. 05, 2023	Feb. 06, 2023	Jan. 11, 2023	Nov. 15, 2022	Nov. 10, 2022	Nov. 09, 2022	Oct. 28, 2022	Feb. 28, 2022	Nov. 30, 2023		Nov. 30, 2022	Nov. 30, 2023		Nov. 28, 2023	Nov. 30, 2022	Feb. 28, 2023	Feb. 28, 2021
Short-Term Debt [Line Items]
Face amount													$ 32,473,346			$ 32,473,346
Less: current portion of loans payable													(9,479,479)			(9,479,479)
Less: discount on non-current loans payable													(4,305,396)			(4,305,396)
Non-current loans payable, net of discount													18,688,471			18,688,471
Current portion of loans payable													9,479,479			9,479,479
Less: discount on current portion of loans payable													1,129,801			1,129,801
Current portion of loans payable, net of discount													$ 8,349,678			$ 8,349,678
Warrant purchase													6,500,000			6,500,000				12,100,000
Fair value of warrants												$ 0									$ 0
Interest expenses													$ 1,581,533		$ 1,271,158	$ 4,940,965			$ 3,448,208
Promissory Note Payable 01 [Member]
Short-Term Debt [Line Items]
Date of issuance	[1],[2]															Jul. 18, 2016
Face amount	[1],[2]												$ 3,500			$ 3,500
Annual interest rate	[1],[2]												22%			22%
Promissory Note Payable 02 [Member]
Short-Term Debt [Line Items]
Date of issuance	[3]															Dec. 10, 2020
Face amount	[3]												$ 3,921,168			$ 3,921,168
Annual interest rate	[3]												12%			12%
Debt settlement amount													$ 2,683,357			$ 2,683,357
Accrued interest													$ 1,237,811			$ 1,237,811
Maturity date																Mar. 01, 2025
Promissory Note Payable 02 [Member] | Warrant [Member]
Short-Term Debt [Line Items]
Common stock issued for debt conversion																$ 3,921,168
Exercise price													$ 0.002			$ 0.002
Fair value of notes																$ 990,000
Promissory Note Payable 03 [Member]
Short-Term Debt [Line Items]
Date of issuance	[4]															Dec. 10, 2020
Face amount	[4]												$ 2,754,338			$ 2,754,338
Annual interest rate	[4]												12%			12%
Debt settlement amount													$ 1,460,794			$ 1,460,794
Accrued interest													1,593,544			$ 1,593,544
Maturity date																Mar. 01, 2025
Face amount													$ 3,054,338			$ 3,054,338
Debt balance																2,754,338
Promissory Note Payable 03 [Member] | Warrant [Member]
Short-Term Debt [Line Items]
Common stock issued for debt conversion																$ 3,054,338
Exercise price													$ 0.002			$ 0.002
Fair value of notes																$ 550,000
Debt repaid													$ 100,000			$ 300,000
Promissory Note Payable 04 [Member]
Short-Term Debt [Line Items]
Date of issuance	[5]															Dec. 10, 2020
Face amount	[5]												$ 165,605			$ 165,605
Annual interest rate	[5]												12%			12%
Debt settlement amount													$ 103,180			$ 103,180
Accrued interest													$ 62,425			62,425
Common stock issued for debt conversion																$ 165,605
Promissory Note Payable 04 [Member] | Warrant [Member]
Short-Term Debt [Line Items]
Exercise price													$ 0.002			$ 0.002
Fair value of notes																$ 176,000
Warrant purchase																80,000,000
Promissory Note Payable 05 [Member]
Short-Term Debt [Line Items]
Date of issuance	[6]															Dec. 14, 2020
Face amount	[6]												$ 310,375			$ 310,375
Annual interest rate	[6]												12%			12%
Debt settlement amount													$ 235,000			$ 235,000
Accrued interest													$ 75,375			75,375
Promissory Note Payable 05 [Member] | Warrant [Member]
Short-Term Debt [Line Items]
Common stock issued for debt conversion																$ 310,375
Exercise price													$ 0.002			$ 0.002
Fair value of notes																$ 182,500
Warrant purchase																25,000,000
Promissory Note Payable 06 [Member]
Short-Term Debt [Line Items]
Date of issuance	[7]															Dec. 30, 2020
Face amount	[7]												$ 350,000			$ 350,000
Annual interest rate	[7]												12%			12%
Debt settlement amount													$ 350,000			$ 350,000
Exercise price													$ 0.025			$ 0.025
Maturity date																Mar. 01, 2025
Debt discount																$ 35,000
Warrants issued																50,000,000
Class of warrant or right warrants term																3 years
Fair value of warrants													$ 271,250			$ 271,250
Debt discount													271,250			271,250
Amortization expens													12,878			105,538
Debt instrument, unamortized discount													31,106			$ 31,106
Promissory Note Payable 07 [Member]
Short-Term Debt [Line Items]
Date of issuance	[8]															Jan. 01, 2021
Face amount	[8]												$ 25,000			$ 25,000
Annual interest rate	[8]												12%			12%
Debt settlement amount													$ 9,200			$ 9,200
Accrued interest													6,944			6,944
Common stock issued for debt conversion																$ 16,144
Maturity date																Mar. 01, 2025
Promissory Note Payable 08 [Member]
Short-Term Debt [Line Items]
Date of issuance	[9]															Jan. 01, 2021
Face amount	[9]												$ 145,000			$ 145,000
Annual interest rate	[9]												12%			12%
Debt settlement amount													$ 79,500			$ 79,500
Accrued interest													28,925			28,925
Common stock issued for debt conversion																$ 108,425
Maturity date																Mar. 01, 2025
Promissory Note Payable 09 [Member]
Short-Term Debt [Line Items]
Date of issuance	[10]															Jan. 14, 2021
Face amount	[10]												$ 550,000			$ 550,000
Annual interest rate	[10]												12%			12%
Debt settlement amount													$ 550,000			$ 550,000
Exercise price													$ 0.025			$ 0.025
Maturity date																Mar. 01, 2025
Debt discount																$ 250,000
Warrants issued																50,000,000
Class of warrant or right warrants term																3 years
Fair value of warrants													$ 380,174			$ 380,174
Debt discount													380,174			380,174
Amortization expens													16,718			129,906
Debt instrument, unamortized discount													50,493			$ 50,493
Promissory Note Payable10 [Member]
Short-Term Debt [Line Items]
Date of issuance	[11]															Feb. 22, 2020
Face amount	[11]												$ 1,650,000			$ 1,650,000
Annual interest rate	[11]												12%			12%
Debt settlement amount													$ 1,650,000			$ 1,650,000
Exercise price													$ 0.135			$ 0.135
Maturity date																Mar. 01, 2025
Debt discount																$ 150,000
Warrants issued																100,000,000
Class of warrant or right warrants term																3 years
Fair value of warrants													$ 1,342,857			$ 1,342,857
Debt discount													1,342,857			1,342,857
Amortization expens													82,499			462,320
Debt instrument, unamortized discount													426,061			$ 426,061
Debt description																The maturity date was extended from February 22, 2022 to February 22, 2024 on February 28, 2022 in exchange for warrants to purchase 50,000,000 at an exercise price of $.0164 and a 3-year term.
Promissory Note Payable10 [Member] | Warrant [Member]
Short-Term Debt [Line Items]
Fair value of warrants													950,000			$ 950,000
Promissory Note Payable 11 [Member]
Short-Term Debt [Line Items]
Date of issuance	[12]															Mar. 01, 2021
Face amount	[12]												$ 6,000,000			$ 6,000,000
Annual interest rate	[12]												12%			12%
Exercise price													$ 0.135			$ 0.135
Warrants issued																300,000,000
Class of warrant or right warrants term																3 years
Debt discount													$ 4,749,005			$ 4,749,005
Proceeds from issuance of debt																5,400,000
Debt conversion original debt amount																600,000
Interest expenses												2,850,000
Promissory Note Payable 11 [Member] | Valuation Technique, Option Pricing Model [Member]
Short-Term Debt [Line Items]
Fair value of warrants																$ 4,749,005
Promissory Note Payable 11 [Member] | Common Stock [Member]
Short-Term Debt [Line Items]
Exercise price													$ 0.0164			$ 0.0164
Warrants issued																150,000,000
Class of warrant or right warrants term																		3 years
Promissory Note Payable 12 [Member]
Short-Term Debt [Line Items]
Date of issuance	[13]															Jun. 08, 2021
Face amount	[13]												$ 2,750,000			$ 2,750,000
Annual interest rate	[13]												12%			12%
Exercise price													$ 0.064			$ 0.064
Debt discount																$ 50,000
Warrants issued																170,000,000
Class of warrant or right warrants term																3 years
Fair value of warrants													$ 2,035,033			$ 2,035,033
Debt discount													2,035,033			2,035,033
Amortization expens													199,482			530,181
Debt instrument, unamortized discount													264,037			$ 264,037
Interest expenses												$ 1,615,000
Promissory Note Payable 12 [Member] | Common Stock [Member]
Short-Term Debt [Line Items]
Exercise price															$ 0.0164				$ 0.0164
Warrants issued																85,000,000
Class of warrant or right warrants term																3 years
Promissory Note Payable 13 [Member]
Short-Term Debt [Line Items]
Date of issuance	[14]															Jul. 12, 2021
Face amount	[14]												$ 3,803,360			$ 3,803,360
Annual interest rate	[14]												7%			7%
Principal ammount													$ 4,000,160			$ 4,000,160
Repayment of notes													27,000			$ 81,000
Promissory Note Payable 14 [Member]
Short-Term Debt [Line Items]
Date of issuance	[15]															Sep. 14, 2021
Face amount	[15]												$ 1,650,000			$ 1,650,000
Annual interest rate	[15]												12%			12%
Exercise price													$ 0.037			$ 0.037
Debt discount																$ 150,000
Warrants issued																250,000,000
Class of warrant or right warrants term																3 years
Fair value of warrants													$ 1,284,783			$ 1,284,783
Debt discount													1,284,783			1,284,783
Amortization expens													146,393			348,667
Debt instrument, unamortized discount													865,764			$ 865,764
Promissory Note Payable 15 [Member]
Short-Term Debt [Line Items]
Date of issuance	[16]															Jul. 28, 2022
Face amount	[16]												$ 170,000			$ 170,000
Annual interest rate	[16]												15%			15%
Maturity date																Mar. 01, 2025
Debt discount																$ 20,000
Amortization expens													$ 0			9,026
Debt instrument, unamortized discount													0			$ 0
Promissory Note Payable 16 [Member]
Short-Term Debt [Line Items]
Date of issuance	[17]															Aug. 30, 2022
Face amount	[17]												$ 3,000,000			$ 3,000,000
Annual interest rate	[17]												15%			15%
Debt discount													$ 39,500			$ 39,500
Amortization expens													4,923			14,216
Debt instrument, unamortized discount													$ 16,552			$ 16,552
Class of warrant or right outstanding													955,000,000			955,000,000
Rate of interest													15%			15%
Class of warrant or right, outstanding																$ 2,960,500
Promissory Note Payable 17 [Member]
Short-Term Debt [Line Items]
Date of issuance	[18]															Sep. 07, 2022
Face amount	[18]												$ 400,000			$ 400,000
Annual interest rate	[18]												15%			15%
Maturity date																Mar. 01, 2025
Debt discount																$ 50,000
Amortization expens													$ 0			27,821
Debt instrument, unamortized discount													0			$ 0
Promissory Note Payable 18 [Member]
Short-Term Debt [Line Items]
Date of issuance	[19]															Sep. 08, 2022
Face amount	[19]												$ 475,000			$ 475,000
Annual interest rate	[19]												15%			15%
Maturity date																Mar. 01, 2025
Debt discount																$ 75,000
Amortization expens													$ 0			36,729
Debt instrument, unamortized discount													0			$ 0
Promissory Note Payable 19 [Member]
Short-Term Debt [Line Items]
Date of issuance	[20]															Oct. 13, 2022
Face amount	[20]												$ 350,000			$ 350,000
Annual interest rate	[20]												15%			15%
Maturity date																Mar. 01, 2025
Debt discount																$ 50,000
Amortization expens													$ 13,295			25,585
Debt instrument, unamortized discount													0			$ 0
Promissory Note Payable 20 [Member]
Short-Term Debt [Line Items]
Date of issuance	[21]															Oct. 28, 2022
Face amount											$ 400,000		$ 400,000	[21]		$ 400,000	[21]
Annual interest rate	[21]												15%			15%
Debt discount											$ 50,000
Amortization expens													$ 3,274			$ 7,613
Debt instrument, unamortized discount													340,411			340,411
Line of credit facility													4,000,000			$ 4,000,000
Promissory Note Payable 21 [Member]
Short-Term Debt [Line Items]
Date of issuance	[21]															Nov. 09, 2022
Face amount										$ 400,000			$ 400,000	[21]		$ 400,000	[21]
Annual interest rate	[21]												15%			15%
Debt discount										$ 50,000
Amortization expens													$ 3,234			$ 7,510
Debt instrument, unamortized discount													340,929			$ 340,929
Promissory Note Payable 22 [Member]
Short-Term Debt [Line Items]
Date of issuance	[21]															Nov. 10, 2022
Face amount									$ 400,000				$ 400,000	[21]		$ 400,000	[21]
Annual interest rate	[21]												15%			15%
Debt discount									$ 50,000
Amortization expens													$ 2,991			$ 6,891
Debt instrument, unamortized discount													343,990			$ 343,990
Promissory Note Payable 23 [Member]
Short-Term Debt [Line Items]
Date of issuance	[21]															Nov. 15, 2022
Face amount								$ 400,000					$ 400,000	[21]		$ 400,000	[21]
Annual interest rate	[21]												15%			15%
Debt discount								$ 50,000
Amortization expens													$ 3,295			$ 7,665
Debt instrument, unamortized discount													340,151			$ 340,151
Promissory Note Payable 24 [Member]
Short-Term Debt [Line Items]
Date of issuance	[21]															Jan. 11, 2023
Face amount							$ 400,000						$ 400,000	[21]		$ 400,000	[21]
Annual interest rate	[21]												15%			15%
Debt discount							$ 50,000
Amortization expens													$ 3,355			$ 7,821
Debt instrument, unamortized discount													339,368			$ 339,368
Promissory Note Payable 25 [Member]
Short-Term Debt [Line Items]
Date of issuance	[21]															Feb. 06, 2023
Face amount						$ 400,000							$ 400,000	[21]		$ 400,000	[21]
Annual interest rate	[21]												15%			15%
Debt discount						$ 50,000
Amortization expens													$ 3,231			$ 7,503
Debt instrument, unamortized discount													340,923			$ 340,923
Promissory Note Payable 26 [Member]
Short-Term Debt [Line Items]
Date of issuance	[21]															Apr. 05, 2023
Face amount					$ 400,000								$ 400,000	[21]		$ 400,000	[21]
Annual interest rate	[21]												15%			15%
Debt discount					$ 50,000
Amortization expens													$ 3,335			$ 6,608
Debt instrument, unamortized discount													339,637			$ 339,637
Promissory Note Payable 27 [Member]
Short-Term Debt [Line Items]
Date of issuance	[21]															Apr. 20, 2023
Face amount				$ 400,000									$ 400,000	[21]		$ 400,000	[21]
Annual interest rate	[21]												15%			15%
Debt discount				$ 50,000
Amortization expens													$ 2,723			$ 4,930
Debt instrument, unamortized discount													347,290			$ 347,290
Promissory Note Payable 28 [Member]
Short-Term Debt [Line Items]
Date of issuance	[21]															May 11, 2020
Face amount			$ 400,000										$ 400,000	[21]		$ 400,000	[21]
Annual interest rate	[21]												15%			15%
Debt discount			$ 50,000
Amortization expens													$ 0			$ 0
Debt instrument, unamortized discount													398,983			$ 398,983
Promissory Note Payable 29 [Member]
Short-Term Debt [Line Items]
Date of issuance	[21]															Oct. 27, 2023
Face amount		$ 400,000											$ 400,000	[21]		$ 400,000	[21]
Annual interest rate	[21]												15%			15%
Debt discount		$ 50,000
Amortization expens													$ 2,044			$ 2,044
Debt instrument, unamortized discount													309,715			$ 309,715
Promissory Note Payable 30 [Member]
Short-Term Debt [Line Items]
Date of issuance	[22],[23]															Nov. 30, 2023
Face amount													$ 477,750			$ 477,750
Annual interest rate	[22],[23]												35%			35%
Class of warrant or right outstanding													350,000			350,000
Rate of interest													35%			35%
Payment terms																thirteen  future monthly payments of $36,750 commencing on April 30,2024 through to April 30, 2025
[1]In default[2]This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender.[3]This promissory note was issued as part of a debt settlement whereby $ 2,683,357 1,237,811 3,921,168 3,921,168 .002 990,000 March 1, 2025 1,460,794 1,593,544 3,054,338 3,054,338 .002 550,000 100,000 300,000 2,754,338 March 1, 2025 103,180 62,425 165,605 165,605 80,000,000 .002 176,000 235,000 75,375 310,375 310,375 25,000,000 .002 182,500 350,000 35,000 50,000,000 0.025 3 271,250 271,250 12,878 105,538 31,106 March 1, 2025 9,200 6,944 16,144 25,000 March 1, 2025 79,500 28,925 108,425 145,000 March 1, 2025 550,000 250,000 50,000,000 0.025 3 380,174 380,174 16,718 129,906 50,493 March 1, 2025 1,650,000 150,000 100,000,000 0.135 3 1,342,857 1,342,857 The maturity date was extended from February 22, 2022 to February 22, 2024 on February 28, 2022 in exchange for warrants to purchase 50,000,000 at an exercise price of $.0164 and a 3-year term. 950,000 82,499 462,320 426,061 March 1, 2025 5,400,000 6,000,000 600,000 300,000,000 0.135 3 4,749,005 4,749,005 150,000,000 .0164 3 2,850,000 2,750,000 50,000 170,000,000 0.064 3 2,035,033 2,035,033 85,000,000 .0164 3 1,615,000 199,482 530,181 264,037 4,000,160 27,000 81,000 1,650,000 150,000 250,000,000 0.037 3 1,284,783 1,284,783 146,393 348,667 865,764 170,000 20,000 0 9,026 0 March 1, 2025 955,000,000 3,000,000 15 2,960,500 39,500 4,923 14,216 16,552 400,000 50,000 0 27,821 0 March 1, 2025 475,000 75,000 0 36,729 0 March 1, 2025 350,000 50,000 13,295 25,585 0 March 1, 2025 4,000,000 400,000 50,000 3,274 7,613 340,411 400,000 50,000 3,234 7,510 340,929 400,000 50,000 2,991 6,891 343,990 400,000 50,000 3,295 7,665 340,151 400,000 50,000 3,355 7,821 339,368 400,000 50,000 3,231 7,503 340,923 400,000 50,000 3,335 6,608 339,637 400,000 50,000 2,723 4,930 347,290 400,000 50,000 0 0 398,983 400,000 50,000 2,044 2,044 309,715 350,000 thirteen future monthly payments of $36,750 commencing on April 30,2024 through to April 30, 2025 477,750 35

Summary of Preferred Stock Warr

Summary of Preferred Stock Warrant Activity (Details) - Preferred Stock [Member] - Warrant [Member]	9 Months Ended
	Nov. 30, 2023 $ / shares shares
Accumulated Other Comprehensive Income (Loss) [Line Items]
Outstanding at beginning | shares	695
Weighted average exercise price at beginning | $ / shares	$ 1
Weighted average remaining years beginning	10 years
Issued | shares	244
Issued | $ / shares	$ 1
Issued	9 years 10 months 17 days
Exercised | shares	0
Exercised | $ / shares
Forfeited and cancelled | shares	0
Forfeited and cancelled | $ / shares
Outstanding at ending | shares	939
Weighted average exercise price at ending | $ / shares	$ 1
Weighted average remaining years ending	9 years 9 months

The table below represent the c

The table below represent the common shares issued, issuable and outstanding at November 30, 2023 and February 28, 2023: (Details) - shares	Nov. 30, 2023	Feb. 28, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issued	7,715,143,227	5,848,741,599
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issued	7,715,143,227	5,836,641,599
Issuable		12,100,000
Issued, issuable and outstanding	7,715,143,227	5,848,741,599

Summary of Common Stock Warrant

Summary of Common Stock Warrant Activity (Details) - Common Stock [Member] - Warrant [Member]	9 Months Ended
	Nov. 30, 2023 $ / shares shares
Accumulated Other Comprehensive Income (Loss) [Line Items]
Outstanding at beginning | shares	314,217,451
Weighted average exercise price at beginning | $ / shares	$ 0.114
Outstanding at beginning (in years)	1 year 11 months 12 days
Issued | shares
Issued | $ / shares
Exercised | shares
Exercised | $ / shares
Forfeited and cancelled | shares
Forfeited and cancelled | $ / shares
Outstanding at ending | shares	314,217,451
Weighted average exercise price at ending | $ / shares	$ 0.114
Outstanding at ending (in years)	1 year 2 months 12 days

Summary of Common Stock Option

Summary of Common Stock Option Activity -Employee Stock Options (Details) - Equity Option [Member] - $ / shares	9 Months Ended
	Nov. 30, 2023	Feb. 28, 2023
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Outstanding at beginning	95,725,000
Outstanding at beginning	$ 0.02
Weighted average remaining years	4 years	4 years 9 months
Issued
Issued
Exercised
Exercised
Forfeited, extinguished and cancelled	(21,275,000)
Forfeited, extinguished and cancelled	$ 0.02
Weighted average remaining years	4 years 7 months 6 days
Outstanding at ending	74,450,000
Outstanding at ending	$ 0.02

STOCKHOLDERS_ EQUITY (DEFICIT_2

STOCKHOLDERS’ EQUITY (DEFICIT) (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Nov. 30, 2023	Aug. 31, 2022	Nov. 30, 2023	Nov. 30, 2022	Feb. 28, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Increase in shares authorization	10,000,000,000		10,000,000,000		10,000,000,000
Issuance of shares	6,500,000		6,500,000		12,100,000
Fair value	$ 44,460		$ 44,460
Payment for services	$ 83,200		83,200
Gain on settlement of debt			$ 38,640
Equity Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of shares	675,336,434		1,859,901,628
Gross proceeds	$ 1,468,477		$ 7,841,466
Net proceeds	1,412,158		7,527,190
Issuance costs	$ 56,320		$ 314,276
Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Increase in shares authorization	7,225,000,000		7,225,000,000
Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Increase in shares authorization	10,000,000,000		10,000,000,000
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Relative fair value	$ 1,209,206		$ 1,209,206
Share based compensation	$ 47,462	$ 150,896	$ 0	$ 0

Summary of rent expense and ope

Summary of rent expense and operating lease cost are recorded over the lease terms on a straight-line basis. (Details)	Nov. 30, 2023 USD ($)
Commitments and Contingencies Disclosure [Abstract]
November 30, 2024	$ 229,016
November 30, 2025	207,558
November 30, 2026	207,558
November 30, 2027	207,558
November 30, 2028	207,558
November 30, 2029 and after	501,599
Total lease payments	1,560,847
Less: Interest	(450,015)
Present value of lease liabilities	$ 1,110,832

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)					3 Months Ended		9 Months Ended
	Jan. 28, 2022	Sep. 30, 2021	Mar. 10, 2021	Dec. 18, 2020	Nov. 30, 2023	Aug. 31, 2022	Nov. 30, 2023	Nov. 30, 2022	Feb. 28, 2023	[1]
Commitments and Contingencies Disclosure [Abstract]
Entity address							the Company entered into a 15-month lease agreement for office space at 18009 Sky Park Circle Suite E
Annual rent	$ 1,500	$ 1,538	$ 15,880	$ 3,859
Security deposit	$ 1,500	$ 18,462	$ 15,880	$ 3,859	$ 17,380		$ 17,380		$ 21,239
Entity address							the Company entered into a 10 year lease agreement for a manufacturing facility at 10800 Galaxie Avenue, Ferndale, Michigan, 48220, commencing on May 1, 2021 through to April 30, 2031 with a minimum base rent of $15,880 per month
Entity address							the Company entered into a 3-year lease agreement for a vehicle commencing September 30, 2021 through to April 30, 2031 with a minimum base rent of $1,538 per month.
Entity address							the Company entered into a 2-year lease agreement for office space at 1516 E Edinger, Santa Ana, California, 92705, commencing on February 1, 2022 through to January 31, 2024 with a minimum base rent of $1,500 per month.
Rent expense and operating lease cost					$ 64,081	$ 61,005	$ 189,164	$ 194,653
[1]Derived from audited information

The net income (loss) per commo

The net income (loss) per common share amounts were determined as follows: (Details) - USD ($)	3 Months Ended						9 Months Ended
	Nov. 30, 2023	Aug. 31, 2023	May 31, 2023	Nov. 30, 2022	Aug. 31, 2022	May 31, 2022	Nov. 30, 2023	Nov. 30, 2022
Earnings Per Share [Abstract]
Net income (loss) available to common shareholders	$ (3,966,484)	$ (4,759,728)	$ (4,555,193)	$ (4,085,660)	$ (4,172,865)	$ (4,671,686)	$ (13,281,405)	$ (12,930,211)
Add: interest expense on convertible debt				22,438				27,863
Add: amortization of debt discount				78,149				90,767
Add (less) loss (gain) on settlement of debt								(3,992)
Add (less) loss (gain) on change of derivative liabilities								(3,595)
Net income (loss) adjusted for common stock equivalents	$ (3,966,484)			$ (3,985,073)			$ (13,281,405)	$ (12,819,168)
Weighted Average Number of Shares Outstanding Basic1	7,294,775,879			5,140,405,652			6,606,988,956	4,969,080,176
Earnings Per Share Basic1	$ 0			$ 0			$ 0	$ 0
Weighted Average Number of Shares Outstanding, Diluted, Adjustment	7,294,775,879			5,140,405,652			6,606,988,956	4,969,080,716
Earnings Per Share Diluted1	$ 0			$ 0			$ 0	$ 0

The anti-dilutive shares of com

The anti-dilutive shares of common stock equivalents for the three and nine months ended November 30, 2023 and 2022 were as follows: (Details) - shares		3 Months Ended		9 Months Ended
		Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2023	Nov. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		27,045,911,584	1,237,643,136	27,045,911,584	1,237,643,136
Series F Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	[1]	26,617,244,133		26,617,244,133
Stock Options and Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		428,667,451	401,217,451	428,667,451	401,217,451
Convertible Debt Securities [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount			836,425,685		836,425,685
[1]On August 23, 2021, the Company filed amended Series F preferred shares such that Series F preferred shares are not convertible into common stock by a holder until (A) August 23, 2023 or (B) the date on which such a conversion may be required for the purpose of (i) uplisting the Company to a new stock exchange, or (ii) selling more than 50% of the Company’s assets. Had these Series F preferred shares been convertible at November 30, 2023 and 2022 the dilutive effects would be as follows:

Series F Preferred shares been

Series F Preferred shares been convertible the dilutive effects would be as follows: (Details) - shares	3 Months Ended		9 Months Ended
	Nov. 30, 2023	Aug. 31, 2022	Nov. 30, 2023	Nov. 30, 2022
Earnings Per Share [Abstract]
Convertible series F preferred shares	0	18,148,779,827	0	18,148,779,827

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - Share Purchase Agreement [Member]	Jan. 12, 2024 USD ($) shares
Subsequent Event [Line Items]
Issuance of shares | shares	639,550
Gross proceeds	$ 1,523,258
Issuance costs	62,980
Net proceeds	$ 1,460,278